###begin article-title 0
###xml 2 7 <span type="species:ncbi:10090">Mouse</span>
###xml 21 26 <span type="species:ncbi:9606">Human</span>
A Mouse Model of the Human Fragile X Syndrome I304N Mutation
###end article-title 0
###begin p 1
Conceived and designed the experiments: JBZ KM LAYP KH RP JCD RBD. Performed the experiments: JBZ EDN CMS LJV KM RZ EFS LAYP JCD. Analyzed the data: JBZ EDN CMS LJV KH RP JCD RBD. Wrote the paper: JBZ KH RP JCD RBD.
###end p 1
###begin p 2
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 511 515 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 517 523 517 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ASFMR1</italic>
###xml 1085 1089 1085 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1195 1199 1195 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 723 730 <span type="species:ncbi:9606">patient</span>
###xml 756 763 <span type="species:ncbi:9606">patient</span>
###xml 925 932 <span type="species:ncbi:9606">patient</span>
###xml 1049 1054 <span type="species:ncbi:10090">mouse</span>
###xml 1129 1133 <span type="species:ncbi:10090">mice</span>
###xml 1205 1210 <span type="species:ncbi:10090">mouse</span>
The mental retardation, autistic features, and behavioral abnormalities characteristic of the Fragile X mental retardation syndrome result from the loss of function of the RNA-binding protein FMRP. The disease is usually caused by a triplet repeat expansion in the 5'UTR of the FMR1 gene. This leads to loss of function through transcriptional gene silencing, pointing to a key function for FMRP, but precluding genetic identification of critical activities within the protein. Moreover, antisense transcripts (FMR4, ASFMR1) in the same locus have been reported to be silenced by the repeat expansion. Missense mutations offer one means of confirming a central role for FMRP in the disease, but to date, only a single such patient has been described. This patient harbors an isoleucine to asparagine mutation (I304N) in the second FMRP KH-type RNA-binding domain, however, this single case report was complicated because the patient harbored a superimposed familial liver disease. To address these issues, we have generated a new Fragile X Syndrome mouse model in which the endogenous Fmr1 gene harbors the I304N mutation. These mice phenocopy the symptoms of Fragile X Syndrome in the existing Fmr1-null mouse, as assessed by testicular size, behavioral phenotyping, and electrophysiological assays of synaptic plasticity. I304N FMRP retains some functions, but has specifically lost RNA binding and polyribosome association; moreover, levels of the mutant protein are markedly reduced in the brain specifically at a time when synapses are forming postnatally. These data suggest that loss of FMRP function, particularly in KH2-mediated RNA binding and in synaptic plasticity, play critical roles in pathogenesis of the Fragile X Syndrome and establish a new model for studying the disorder.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 278 285 <span type="species:ncbi:9606">patient</span>
###xml 524 529 <span type="species:ncbi:10090">mouse</span>
Missense mutations in human genes provide valuable insight into the genetic causes of disease. Fragile X Syndrome (FXS), a common genetic cause of autism and mental retardation, is usually caused by transcriptional silencing of the FMR1 gene. The potential importance of single patient with a missense mutation (I304N) in an RNA-binding domain of the Fragile X protein, FMRP, has been questioned in part because he has a confounding liver disease. We introduced the I304N mutation into the endogenous Fmr1 locus to create a mouse model of Fragile X Syndrome. We find that this mutation results in behavioral, electrophysiologic, and phenotypic features of the disease, loss of binding to RNA targets in the brain, and lower FMRP levels at a critical time during synapse formation. We conclude that loss of RNA binding and underexpression of FMRP are sufficient to cause the Fragile X Syndrome.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 276 279 276 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Jamain1">[1]</xref>
###xml 280 283 280 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Tabuchi1">[2]</xref>
###xml 296 299 296 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Feng1">[3]</xref>
###xml 309 312 309 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Durand1">[4]</xref>
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-VandenVeyver1">[5]</xref>
###xml 586 589 586 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-1">[6]</xref>
###xml 713 717 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 829 832 829 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-ODonnell1">[7]</xref>
###xml 908 912 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR4</italic>
###xml 914 921 914 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS-FMR1</italic>
###xml 1083 1086 1083 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Khalil1">[8]</xref>
###xml 1087 1090 1087 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Ladd1">[9]</xref>
###xml 1237 1244 1237 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1529 1533 1529 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-DeBoulle1">[10]</xref>
###xml 1750 1754 1750 1754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-DeBoulle1">[10]</xref>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 1222 1229 <span type="species:ncbi:9606">patient</span>
###xml 1317 1324 <span type="species:ncbi:9606">patient</span>
###xml 1657 1664 <span type="species:ncbi:9606">patient</span>
###xml 1710 1717 <span type="species:ncbi:9606">patient</span>
Missense mutations have been especially informative for establishing links between genetics and protein function in human disease. For example, missense mutations have advanced our understanding of the relationship between autism and mutations in genes including neuroligin-3 [1],[2], neurexin-1 [3], shank 3 [4], and MeCP2 [5]. Such mutations have not generally been of help in understanding the devastating effects of the loss of function of the Fragile X mental retardation protein (FMRP), which include complex behavioral deficits including mental retardation, autism, and seizures [6]. In nearly all cases, the Fragile X Syndrome is caused by transcriptional silencing of the fragile X mental retardation 1 (FMR1) gene as a result of CGG repeat expansion and hypermethylation of CpG islands in the 5'UTR region (reviewed in [7]), culminating in loss of FMRP expression. Moreover, antisense transcripts (FMR4, AS-FMR1) in the same locus have been reported to be silenced by the repeat expansion, raising the possibility that their loss of function may contribute to the syndrome [8],[9]. While this transcriptional silencing precludes structure-function analysis of FMRP, a single severely affected Fragile X Syndrome patient with a de novo missense mutation in FMRP has the potential to address this issue. This patient has marked macroorchidism, with testicular volume exceeding 100ml, and mental retardation, with IQ measured below 20, and harbors a mutation in a conserved isoleucine changing it to an asparagine (I304N) [10]. Nonetheless, uncertainty has surrounded the significance of this clinical observation, in part because only a single such patient has been described, and in part because this patient has a confounding liver disease [10].
###end p 6
###begin p 7
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 100 106 100 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Cgr</sup>
###xml 96 106 96 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>tm1Cgr</sup></italic>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Huber1">[11]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Zhao1">[18]</xref>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Nimchinsky1">[19]</xref>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Comery1">[20]</xref>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Rudelli1">[21]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Hinton1">[22]</xref>
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
###xml 233 238 <span type="species:ncbi:9606">human</span>
Previous efforts at modeling defects in FMRP have centered on generation of an Fmr1 null mouse (Fmr1tm1Cgr). This mouse has defects in synaptic plasticity [11]-[18] and long, thin dendritic spines [19],[20] similar to those found in human brain [21],[22]. Understanding the biochemical mechanism by which FMRP mediates proper synaptic plasticity and/or maturation is an area of intense interest.
###end p 7
###begin p 8
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Khandjian1">[23]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Feng2">[25]</xref>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Feng3">[26]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Khandjian2">[28]</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Caudy1">[29]</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Jin1">[32]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Vasudevan1">[33]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Vasudevan2">[34]</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-DeDiegoOtero1">[35]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Ferrari1">[37]</xref>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Zalfa1">[38]</xref>
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
###xml 192 197 <span type="species:ncbi:10090">mouse</span>
###xml 335 345 <span type="species:ncbi:7227">Drosophila</span>
Studies of FMRP have been necessarily restricted to in vitro and cell culture models, since the mouse model is a null. FMRP associates with polyribosomes in tissue culture cells [23]-[25] and mouse brain [26]-[28]. Moreover, FMRP, and the related protein FXR1P, associate with components of the RNA-induced silencing complex (RISC) in Drosophila and mammalian cells [29]-[32], and FXR1P is required to mediate miRNA-dependent translational activation in tissue culture cells [33],[34]. FMRP has also been proposed to have a role in mRNA transport, trafficking mRNA targets as granules from cytoplasm to synapses in a microtubule-dependent manner in primary neurons [35]-[37]. FMRP has also been suggested to regulate PSD-95 mRNA stability [38]. A common theme associated with these diverse cellular roles is that a critical function of FMRP is binding to specific RNA targets.
###end p 8
###begin p 9
###xml 183 184 183 184 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</underline>
###xml 184 185 184 185 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</underline>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Siomi1">[39]</xref>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Siomi2">[40]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Mazroui1">[41]</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Reeve1">[44]</xref>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Bardoni1">[45]</xref>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Zhang1">[46]</xref>
###xml 686 690 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Eberhart1">[47]</xref>
###xml 850 854 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Fridell1">[48]</xref>
FMRP has functional domains involved in RNA binding, protein:protein interactions and nuclear-cytoplasmic shuttling. FMRP RNA binding domains include two tandem KH-type domains (hnRNPKhomology), an arginine and glycine-rich RNA binding domain (RGG box) [39],[40], and an N-terminal domain similar to Tudor/Agenet domains that may be involved in both RNA binding and protein-protein interactions [41]-[44]. Protein interaction domains include an N-terminal region responsible for homodimerization and heterodimerization with its autosomal homologs FXR1P and FXR2P [45],[46]. Finally, FMRP has a nuclear localization signal (NLS) mapped to approximately 100 nucleotides of the N-terminus [47], and a Rev-like nuclear export signal (NES) C-terminal to the KH domains, which, when mutated at critical leucines, causes accumulation of FMRP in the nucleus [48].
###end p 9
###begin p 10
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Ramos2">[49]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Lewis1">[50]</xref>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Lewis1">[50]</xref>
###xml 614 618 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell1">[51]</xref>
###xml 690 704 690 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1(I304N)Drnl</sup>
###xml 686 704 686 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>tm1(I304N)Drnl</sup></italic>
###xml 722 727 722 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 718 727 718 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 803 807 803 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1162 1167 1162 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 1158 1167 1158 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 435 442 <span type="species:ncbi:9606">patient</span>
###xml 679 684 <span type="species:ncbi:10090">mouse</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 1168 1173 <span type="species:ncbi:10090">mouse</span>
Interest in the RNA binding properties of the KH2 domain has been heightened by structural data suggesting that the human I304N mutation maps to the RNA binding pocket present in KH domains [49]. For example, the first structure of a KH domain (Nova KH3) bound to its RNA ligand demonstrated that the RNA binding pocket is supported by conserved hydrophobic amino acids, one of which corresponds to the isoleucine mutated in the I304N patient [50]. These observations have suggested that a key defect in FMRP loss-of-function is the loss of sequence-specific RNA binding, mediated through the FMRP KH2 domain [50],[51]. Here we address these issues by generating and analyzing a mouse (Fmr1tm1(I304N)Drnl, termed here Fmr1I304N) harboring the I304N mutation. We find that the I304N mutation phenocopies Fmr1 null mice. The mutant protein has lost polyribosome association and RNA binding, and is present at reduced levels that vary with age, but are particularly low at P14, during synaptogenesis. These observations support the suggestion that sufficient levels of FMRP, and/or its RNA binding activity, are critical for normal cognition. Generation of the Fmr1I304N mouse provides a new model for understanding molecular defects in the disease, for screening potential therapies, and heightens interest in identifying FMRP-RNA interactions in the brain.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Generation and characterization of Fmr1 I304N mice
###end title 12
###begin p 13
###xml 16 21 16 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 12 21 12 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 126 135 126 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g001">Figure 1A</xref>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 220 221 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Bunting1">[52]</xref>
###xml 440 449 440 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g001">Figure 1B</xref>
###xml 496 501 496 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 492 501 492 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
To generate Fmr1I304N mice we introduced the I304N mutation into the endogenous mouse Fmr1 locus by homologous recombination (Figure 1A). An Fmr1 KH2 I304N targeting construct, including a self-excising loxP-Auto-Cre-NeoR-loxP (ACNF) cassette which allows self-induced deletion of the selectable marker in the male germline [52], was electroporated into embryonic stem cells and 53 homologous recombinants were identified by Southern blot (Figure 1B). Germline chimeras were bred to generate Fmr1I304N mice. These were bred for greater than 10 generations into both FVB and C57BL/6J backgrounds.
###end p 13
###begin title 14
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Generation of the Fmr1 I304N knock-in mouse model.
###end title 14
###begin p 15
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 118 119 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 659 663 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 679 683 679 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 683 688 683 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 721 729 721 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 792 796 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1019 1023 1016 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1152 1157 1149 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 1231 1235 <span type="species:ncbi:10090">mice</span>
(A) The KH2-I304N Fmr1 targeting construct introduces an isoleucine to asparagine mutation in exon 10. An Auto-Cre-NeoR (ACNF) cassette for selection and auto-excision in the male germline was inserted in a non-conserved region of intron 10. (B) Southern blot analysis of representative ES cells transfected with the I304N Fmr1 targeting construct. DNA from ES cell clones was digested with BamHI and probed for recombination by Southern blot using a probe outside the targeting construct (dotted line in (A)). The targeted allele, 2.7kb (clones 3, 4, 6-8), can be distinguished from the wild type locus, 9.6kb. (C) Brain (B) and testicular (T) mRNA from WT, Fmr1 null (KO), and Fmr1I304N (I304N) mice was probed with an in vitro transcribed radiolabeled RNA probe anti-sense to the 3'UTR of Fmr1 and visualized by Northern blot. beta-actin mRNA was detected with an oligo probe. (D) RNA prepared from brain as in (C) was quantified by quantitative RT-PCR with two sets of primers encompassing different regions of the Fmr1 mRNA, including primers spanning exons 2 to 3 (left panel) and primers spanning exons 10 to 11 (right panel), and normalized to Gapdh and WT mRNA levels. Error bars reflect the standard deviation from three mice of each genotype.
###end p 15
###begin p 16
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 49 54 49 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 45 54 45 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 319 335 319 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g001">Figure 1C and 1D</xref>
###xml 381 386 381 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
We examined Fmr1 mRNA expression in male FVB Fmr1I304N mice. Because the Fmr1 gene is on the X chromosome these mice express only the I304N-mutant allele. Northern blot and quantitative RT-PCR analysis showed that I304N Fmr1 mRNA was expressed at wild type levels and was of the expected size in both brain and testes (Figure 1C and 1D). Sequencing of RT-PCR products from the Fmr1I304N mice confirmed the presence of the I304N mutation (data not shown).
###end p 16
###begin p 17
###xml 4 9 4 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 317 322 317 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 313 322 313 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 633 718 633 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000758.s001">Figure S1A, S1B, S1C, S1D, S1E, S1F, S1G, S1H, S1I, SIJ, S1K, S1L, S1M, S1N, S1O, S1P</xref>
###xml 732 736 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Peier1">[53]</xref>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-DutchBelgian1">[54]</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 499 507 <span type="species:ncbi:9606">patients</span>
###xml 523 530 <span type="species:ncbi:9606">patient</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
Fmr1I304N mice had no overt phenotype, were fertile with normal litter sizes, and transmitted the mutant allele with the expected X-linked Mendelian segregation ratios. Histological examination of heart, spleen, liver, lung, kidney, adrenal glands, stomach, intestines, muscles, diaphragm, bladder, and thymus of Fmr1I304N mice revealed no macroscopic abnormalities nor microscopic lesions (data not shown). Further analysis focused on the brain and testes, as both organs are affected in Fragile X patients, and the I304N patient in particular. Histologic analysis of cerebellum, cortex, hippocampus and testes revealed no defects (Figure S1A, S1B, S1C, S1D, S1E, S1F, S1G, S1H, S1I, SIJ, S1K, S1L, S1M, S1N, S1O, S1P), similar to Fmr1 null mice [53],[54].
###end p 17
###begin p 18
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Turner1">[55]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-DeBoulle1">[10]</xref>
###xml 280 285 280 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 276 285 276 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 373 378 373 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 369 378 369 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 501 510 501 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g002">Figure 2A</xref>
###xml 538 543 538 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 534 543 534 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 628 637 628 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g002">Figure 2B</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Peier1">[53]</xref>
###xml 644 648 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-DutchBelgian1">[54]</xref>
###xml 715 720 715 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 711 720 711 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 743 747 743 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 766 782 766 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g002">Figure 2C and 2D</xref>
###xml 178 185 <span type="species:ncbi:9606">patient</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
###xml 887 892 <span type="species:ncbi:9606">human</span>
###xml 893 901 <span type="species:ncbi:9606">patients</span>
###xml 970 977 <span type="species:ncbi:9606">patient</span>
Macroorchidism of greater than 25 ml combined testicular volume is present in more than 90% of adult males with Fragile X syndrome [55], and was particularly severe in the I304N patient whose testicular volume exceeded 100 ml [10]. We measured the testicular weights of adult Fmr1I304N mice compared to either WT or Fmr1 null littermates. Macroorchidism was evident in Fmr1I304N mice compared to WT animals (12-28% increased weight), and the most pronounced differences were evident in older animals (Figure 2A). Testicular weight in Fmr1I304N mice was similar to, but surprisingly, no greater than that seen in FMR1 null mice (Figure 2B; [53],[54]). There was no significant difference in body weights between Fmr1I304N mice and wild type or Fmr1 null littermates (Figure 2C and 2D). These observations indicate that the I304N mutation in mice phenocopies the macroorchidism evident in human patients, and suggests that the profound macroorchidism evident in the I304N patient may result from a combination of the I304N mutation and additional factors.
###end p 18
###begin title 19
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 4 9 4 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 110 116 110 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Cgr</sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
Fmr1I304N mice are macroorchid compared with WT littermates and have the same degree of macroorchidism as Fmr1tm1Cgr littermates.
###end title 19
###begin p 20
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 51 56 51 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 281 285 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 285 290 285 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 380 384 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 384 389 380 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 475 479 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 479 484 471 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 574 578 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 578 583 566 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 672 676 656 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 676 681 660 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 798 802 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 802 807 782 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 851 855 831 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 914 918 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
(A) Combined weights (W) of both testes of FVB.Fmr1I304N mice (n = 43) were compared with their wild type FVB littermates (n = 34). For statistical analysis, litters of similar ages were grouped together and data were subject to student's t-test. Age 17-19 days, weight (W) of the Fmr1I304N mice = 0.031+/-0.003g (n = 6), W(WT) = 0.042+/-0.007g (n = 3), p>0.05; age 31-33 days, W(Fmr1I304N) = 0.130+/-0.009g (n = 6), W(WT) = 0.134+/-0.008g (n = 6), p>0.05; age 65-79 days, W(Fmr1I304N) = 0.224+/-0.005g (n = 14), W(WT) = 0.195+/-0.005 (n = 13), *p<0.03; age 117-119 days, W(Fmr1I304N) = 0.263+/-0.006g (n = 11), W(WT) = 0.234+/-0.010 (n = 6), *p<0.03; age 196-233 days, W(Fmr1I304N) = 0.243+/-0.014g (n = 6), W(WT) = 0.190+/-0.007 (n = 6), **p<0.001. (B) Combined weights (W) of both testes of FVB.Fmr1I304N mice (n = 32) were compared with their FVB.Fmr1 null littermates (n = 28). (C) Body weights from the same mice in (A). (D) Body weights from the same mice in (C).
###end p 20
###begin title 21
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Behavioral analysis of I304N mice
###end title 21
###begin p 22
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Bernardet1">[56]</xref>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Kooy1">[57]</xref>
###xml 234 239 234 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 230 239 230 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Brennan1">[58]</xref>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-McIlwain1">[59]</xref>
###xml 675 680 675 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 671 680 671 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 778 785 778 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000758-t001">Table 1</xref>
###xml 787 796 787 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000758.s002">Figure S2</xref>
###xml 802 809 802 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000758.s003">Text S1</xref>
###xml 957 962 957 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 953 962 953 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 1058 1062 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1078 1085 1078 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000758.s003">Text S1</xref>
###xml 1168 1173 1168 1173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 1164 1173 1164 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>I304N</sup></italic>
###xml 1224 1228 1224 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 877 881 <span type="species:ncbi:10090">mice</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 982 986 <span type="species:ncbi:10090">mice</span>
###xml 1068 1072 <span type="species:ncbi:10090">mice</span>
###xml 1174 1178 <span type="species:ncbi:10090">mice</span>
###xml 1234 1238 <span type="species:ncbi:10090">mice</span>
###xml 1385 1389 <span type="species:ncbi:10090">mice</span>
Modeling the human behavior deficits seen in Fragile X Syndrome in mouse models has proven challenging, although some marked differences between Fmr1 null mice and normal littermates have been characterized [56],[57]. We compared Fmr1I304N and WT littermates in behavioral assays, blind to genotype. We assessed a battery of 11 behavioral tests that are well established measures of deficits in Fmr1 null mice [58],[59]. These included measures of exploratory behavior, anxiety, acoustic startle and prepulse inhibition, conditioned fear, pain sensitivity, marble burying (as a measure of perseverative behavior), and susceptibility to audiogenic seizure. Results in the Fmr1I304N mice were consistent with lower levels of anxiety and greater repetitive/perseverative behavior (Table 1, Figure S2, and Text S1). Importantly, one of the most robust phenotypes in Fragile X null mice, increased susceptibility to audiogenic seizure, was evident in 18% of Fmr1I304N mice but not in WT mice; these results are comparable to or more severe than those reported in Fmr1 null mice (see Text S1 for discussion). Taken together, our results indicate that in 10 of 11 tests, Fmr1I304N mice show similar responses to those reported for Fmr1 null mice. Both are hyperactive, have increased perseverative behavior and audiogenic seizures, and reduced anxiety and startle reflexes relative to normal mice.
###end p 22
###begin title 23
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 85 91 85 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Cgr</sup>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Tabulation of behavioral test summary and comparison with historical findings on Fmr1tm1Cgr null mice.
###end title 23
###begin p 24
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Spencer3">[68]</xref>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Yan1">[89]</xref>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
Assays marked with an asterisk indicate areas of discrepancy with the literature. Prior studies of prepulse-inhibition [68] found a trend toward a decrease in PPI, as seen here, although others have reported it to be increased. The audiogenic seizure experiments were performed on 2-3 month old I304N mice and WT littermates, and the Fmr1 null mice have not previously been reported to display audiogenic seizures beyond the age of 7 weeks in a C57Bl/6 background [89] although they consistently display audiogenic seizures at younger ages.
###end p 24
###begin title 25
###xml 15 19 <span type="species:ncbi:10090">mice</span>
I304N knock-in mice have altered synaptic plasticity in hippocampus
###end title 25
###begin p 26
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 210 217 210 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Huber1">[11]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Hou1">[60]</xref>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Nosyreva1">[61]</xref>
###xml 655 659 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 659 664 659 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 852 868 852 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g003">Figure 3A and 3C</xref>
###xml 920 924 920 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 924 929 924 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 936 952 936 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g003">Figure 3B and 3D</xref>
###xml 1024 1028 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1028 1033 1028 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 1123 1127 1123 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1220 1230 1220 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Discussion</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
###xml 1133 1137 <span type="species:ncbi:10090">mice</span>
###xml 1210 1214 <span type="species:ncbi:10090">mice</span>
Fmr1 null mice have defects in synaptic plasticity. The most well-studied relates to metabotropic glutamate receptor-dependent long term depression (mGluR-LTD) in hippocampal CA1 neurons that normally requires de novo protein synthesis in dendrites. In Fmr1 null mice, mGluR-LTD elicited by either an mGluR agonist (DHPG) or electrical stimulation of Schaffer collateral inputs to CA1 neurons (paired pulse low frequency stimulation (PP-LFS)) is enhanced [11], and no longer requires protein synthesis [60],[61]. We assayed the protein synthesis requirement for both chemically and synaptically induced mGluR-LTD in acute hippocampal slices prepared from Fmr1I304N mice and their wild type littermates. Pre-incubation with the protein synthesis inhibitor anisomycin inhibited both DHPG (p = 0.003) and PP-LFS (p = 0.003) induced LTD in wild type mice (Figure 3A and 3C), but had no effect on the establishment of LTD in Fmr1I304N mice (Figure 3B and 3D). LTD magnitude in the absence of anisomycin was not different between Fmr1I304N and wild type littermates. We also found no significant difference between wild type and Fmr1 null mice in these studies, consistent with the lack of enhanced LTD in the I304N mice (see Discussion).
###end p 26
###begin title 27
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 47 52 47 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Protein synthesis-independent mGluR-LTD in Fmr1I304N mice.
###end title 27
###begin p 28
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 109 114 109 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 283 288 283 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 422 427 422 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 481 486 481 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 713 717 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 717 722 717 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 738 742 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
Evoked extracellular field potentials (FPs) from CA1 of acute slices from 30-90 day old wild-type and B6.Fmr1I304N littermates are plotted as a percent of baseline (pre-DHPG or PP-LFS). (A,B) Anisomycin inhibits DHPG-induced LTD in wild-type littermates, but has no effect in B6.Fmr1I304N mice (*; p = 0.02). (C,D) Anisomycin inhibits synaptically induced LTD (with PP-LFS; *; p = 0.004) in wild type mice, but not B6.Fmr1I304N mice. The magnitude of LTD between wild type and Fmr1I304N mice is not different under control conditions, but is enhanced in the presence of anisomycin (ANOVA and subsequent Fisher PLSD; p<0.05). (E) There is no difference in the degree of LTD elicited by DHPG stimulation between B6.Fmr1I304N mice and their Fmr1 null littermates.
###end p 28
###begin p 29
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 145 150 145 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 229 234 229 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 332 341 332 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g003">Figure 3E</xref>
###xml 25 32 <span type="species:ncbi:9606">patient</span>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
Finally, since the I304N patient is more severely affected than typical Fragile X patients, we examined whether mGluR-LTD is enhanced in the Fmr1I304N relative to Fmr1 null mice. We compared DHPG-elicited LTD measurements in Fmr1I304N and Fmr1 null littermates, and found that there was no difference in the degree of LTD elicited (Figure 3E).
###end p 29
###begin p 30
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 77 82 77 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 298 303 <span type="species:ncbi:10090">mouse</span>
Taken together, given the degree of similarity in the phenotypes between Fmr1I304N and Fmr1 null mice, including their behavior, macroorchidism and altered synaptic plasticity, we conclude that the I304N mutation in FMRP is sufficient to cause symptoms of the Fragile X Syndrome. We next used this mouse model to address the mechanism by which this missense mutation in the KH2 RNA-binding domain of FMRP results in the Fragile X phenotype.
###end p 30
###begin title 31
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
I304N FMRP levels in the I304N mouse
###end title 31
###begin p 32
###xml 250 266 226 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g004">Figure 4A and 4B</xref>
###xml 546 562 510 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g004">Figure 4A and 4B</xref>
###xml 670 679 634 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g004">Figure 4C</xref>
###xml 835 844 787 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g004">Figure 4D</xref>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 286 289 <span type="species:ncbi:10090">P14</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
We examined I304N-FMRP expression in the brain, testes, and spleen by Western blot analysis. At 2 months of age, I304N-FMRP was expressed at approximately30% of normal levels in brain and remained at approximately30% of WT levels at 6 months of age (Figure 4A and 4B). In younger mice (P14), WT FMRP levels were much higher, while I304N-FMRP was expressed at levels only slightly higher than in older mice, leading to a relatively larger difference between WT and I304N FMRP levels in the second postnatal week (approximately13% of the WT level; Figure 4A and 4B). We found no evidence for a compensatory increase of the FMRP homologues, FXR1P and FXR2P, in I304N mice (Figure 4C). I304N-FMRP was also present at lower steady-state levels than the WT protein in other tissues (approximately30% in testes and spleen at 6 months of age; Figure 4D).
###end p 32
###begin title 33
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 26 31 26 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
Expression of FMRP in Fmr1I304N and WT littermates.
###end title 33
###begin p 34
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 41 46 41 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Gabel1">[84]</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Brown2">[85]</xref>
###xml 1008 1012 1008 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1012 1017 1012 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 1113 1117 1113 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1127 1132 1127 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 87 90 <span type="species:ncbi:10090">P14</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 673 676 <span type="species:ncbi:10090">P14</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 1018 1022 <span type="species:ncbi:10090">mice</span>
###xml 1271 1275 <span type="species:ncbi:10090">mice</span>
(A) 50 ug of brain lysate from three Fmr1I304N mice and three wild type littermates at P14, 2 mo, and 6 mo of age, were analyzed by Western blot for steady state FMRP expression using the anti-FMRP C-terminus antisera ab17722 (Abcam) and gamma-tubulin as a loading control. (B) Signal was quantified by chemiluminescence using Versadoc imaging and the percentage of I304N-FMRP signal compared to wild type FMRP is indicated. Error bars reflect the standard deviation of three mice. This experiment has been repeated several times and with different antibodies to FMRP (Chemicon ab2160 (1C3), 2F5 [84], and 7G1-1 [85] with consistent results. (C) 50 ug of brain lysate from P14 mice of the indicated genotype (littermates) was analyzed for expression of FMRP with ab17722, FXR1P, FXR2P, and gamma-tubulin. (D) 50ug of testes or spleen lysate from the same animals at P60 was analyzed in the same way with ab17722, and normalized to Hsp90 levels. (E) Brain lysates for polyribosome analysis were prepared from Fmr1I304N mice and WT littermates, and fractionated over linear 20%-50% sucrose gradients. The levels of Fmr1 mRNA and Gapdh mRNA were quantified in each fraction by quantitative RT-PCR using the DeltaDeltaCt method. An A254 absorption profile from one of the WT mice is shown in the upper panel and the 80S monosome and polyribosomes are indicated. Other gradients were indistinguishable within a WT and I304N littermate pair. Relative mRNA level in each fraction was plotted as a percentage of total mRNA to illustrate its distribution over the polyribosome gradient. Error bars reflect three technical replicates from a single littermate pair. The experiment has been repeated with additional littermate pairs, but cannot be plotted on one graph due to variable fraction collection between experiments. Representative graphs are shown.
###end p 34
###begin p 35
###xml 63 79 63 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g001">Figure 1C and 1D</xref>
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 456 465 456 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g004">Figure 4E</xref>
###xml 298 301 <span type="species:ncbi:10090">P14</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
Decreased protein steady-state levels with normal mRNA levels (Figure 1C and 1D) suggests that I304N-FMRP may either be synthesized more slowly or turned over more rapidly. We analyzed whether I304N Fmr1 mRNA was being translated by comparing its distribution on polyribosomes with WT Fmr1 mRNA in P14 mice. Quantitative RT-PCR analysis of mRNA levels showed that I304N Fmr1 and WT Fmr1 mRNA had similar distributions across 16 sucrose gradient fractions (Figure 4E). These observations suggest that the lower I304N-FMRP levels do not relate to translational control, but may relate to increased turnover of the mutant protein, particularly in younger mice.
###end p 35
###begin title 36
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
I304N FMRP function in the I304N mouse
###end title 36
###begin p 37
###xml 59 63 59 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Khandjian1">[23]</xref>
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Feng2">[25]</xref>
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Feng3">[26]</xref>
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Khandjian2">[28]</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Feng2">[25]</xref>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell2">[62]</xref>
###xml 535 539 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 539 544 539 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 552 555 552 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">254</sub>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 673 678 673 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 861 870 861 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g005">Figure 5A</xref>
###xml 962 971 962 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g005">Figure 5B</xref>
###xml 1106 1115 1106 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g005">Figure 5A</xref>
###xml 1273 1277 1273 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Feng2">[25]</xref>
###xml 217 224 <span type="species:ncbi:9606">patient</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 679 684 <span type="species:ncbi:10090">mouse</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
###xml 848 853 <span type="species:ncbi:10090">mouse</span>
###xml 1093 1098 <span type="species:ncbi:10090">mouse</span>
###xml 1239 1246 <span type="species:ncbi:9606">patient</span>
FMRP associates with polyribosomes in tissue culture cells [23]-[25] and in brain [26]-[28], suggesting that the protein may regulate mRNA translation. In contrast, in lymphoblastoid cell lines derived from the I304N patient, and in cells transfected with an EGFP-tagged I304N-FMRP reporter construct, mutant FMRP no longer associates with polyribosomes [25],[62]. To examine whether the I304N mutation affected endogenous FMRP-polyribosome association in the brain, we examined the distribution of the mutant protein in the brains of Fmr1I304N mice. A254 traces of polyribosomes separated by sucrose density centrifugation revealed no difference between wild type and Fmr1I304N mouse brain, suggesting that global translation status was normal in the mutant mice (data not shown). However, I304N-FMRP was largely dissociated from polyribosomes in mouse brain (Figure 5A), and there was a reciprocal increase in I304N-FMRP present in lighter polysome fractions (Figure 5B). We also found that the I304N mutation in FMRP does not significantly affect FXR1P or FXR2P polyribosome association in mouse brain (Figure 5A), suggesting that their polysome-association is not FMRP-dependent. These results are consistent with previous findings in patient lymphoblastoid cell lines [25], and suggest that the I304N mutation impacts the normal function of FMRP on polyribosomes.
###end p 37
###begin title 38
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Endogenous I304N-FMRP is dissociated from polyribosomes in mouse brain.
###end title 38
###begin p 39
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 53 58 53 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 660 664 660 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 664 669 664 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 4 9 <span type="species:ncbi:10090">Mouse</span>
(A) Mouse brain cytoplasmic extracts from WT and Fmr1I304N littermates (second postnatal week) were separated on 20-50% linear sucrose gradients. The positions of the 80S monosome and polyribosomes are indicated on the A254 profile from each gradient (top panel). FMRP (detected with either 17722 or 7G1-1 antibody, to insure no crossreactivity with FXR1P and FXR2P)), FXR1P (ML13 antibody), and FXR2P (1G2 antibody) distributions were analyzed by Western blot. Ribosomal protein S6 (S6P) distribution confirms the integrity of the polyribosomes. (B) Quantification of chemiluminescence by Versadoc imaging of the Western blot of FMRP distribution from WT and Fmr1I304N littermates; values reflect the percentage of FMRP present in each fraction relative to total FMRP in the gradient. Errors bars reflect the standard deviation of the technical replicates. Quantification of this data revealed that very little wild type FMRP was present in fractions containing less than 2 ribosomes per transcript (fractions 1-5) and more than 55% was present on heavy polyribosomes (fractions 9-13), while 44% of total I304N-FMRP was in the corresponding light fractions (1-5) with a corresponding loss from the heavy polyribosomes. The experiment was repeated multiple times with additional littermate pairs with very similar results.
###end p 39
###begin title 40
The endogenous I304N-FMRP complex is abnormally small due to loss of RNA binding by mutant FMRP
###end title 40
###begin p 41
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Feng2">[25]</xref>
###xml 455 464 455 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g006">Figure 6A</xref>
###xml 599 608 599 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g006">Figure 6A</xref>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Feng2">[25]</xref>
###xml 847 856 847 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g006">Figure 6A</xref>
###xml 212 217 <span type="species:ncbi:10090">mouse</span>
###xml 710 717 <span type="species:ncbi:9606">patient</span>
It has been suggested that the I304N mutation renders FMRP incapable of forming normal mRNP complexes in cultured cells [25]. We analyzed endogenous WT or I304N-FMRP particle size by Superose 6 gel filtration of mouse brain cytoplasmic extracts prepared in EDTA to release ribosomal subunits from mRNA. Wild type FMRP was found in the void volume of the Superose 6 column, indicating that FMRP is normally present in a complex of greater than 40,000 kDa (Figure 6A, upper left panels). In contrast, the majority of I304N-FMRP was shifted into a smaller complex eluting at approximately 100-300 kDa (Figure 6A, lower left panels). This complex may correspond to a small (<440kD) I304N complex observed in I304N patient-derived lymphoblastoid cells [25]. Mutant I304N-FMRP had no significant effect on the apparent size of FXR1P or FXR2P complexes (Figure 6A, left panels).
###end p 41
###begin title 42
Endogenous I304N-FMRP is in an abnormally small and RNase resistant complex.
###end title 42
###begin p 43
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 214 219 214 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 1056 1060 1056 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1060 1065 1060 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 1586 1590 1586 1590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1590 1595 1590 1595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 1855 1859 1855 1859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1859 1864 1859 1864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 641 646 <span type="species:ncbi:9606">human</span>
###xml 647 654 <span type="species:ncbi:9606">patient</span>
###xml 2138 2143 <span type="species:ncbi:10090">mouse</span>
(A) The migration of standards including blue dextran for the void volume, and proteins of 669, 440, and 67 kDa used to calibrate the Superose 6 3.2/30 column are shown. Brain lysates were prepared from WT and Fmr1I304N littermates (P22), treated with EDTA to disrupt polyribosomes, and treated with or without an overdigestion with RNases as indicated, and applied to a Superose 6 column sequentially. Two gradients for each condition were pooled to obtain enough material from eluted fractions for Western blot. Column fractions were TCA precipitated and Western blotted for wild type or I304N-FMRP (1C3), FXR1P (ML13), FXR2P (1G2), Nova (human patient antisera) and hsp90. (Upper left) The wild-type FMRP mRNP complex eluted in the void volume of the column (fraction 4) corresponding to a size of >40,000 kDa, as do most of FXR1P and FXR2P. FXR2P is shown by the upper band (arrow) as the FMRP blot was reprobed with 1G2 without stripping. (Lower left) I304N-FMRP is in a much smaller complex of 100-400 kDa (fractions 13 and 14). Most of FXR1P in the Fmr1I304N lysate remains in the void volume though there is a small increase in fractions 11-14. FXR2P (arrow) remains in the void volume. (Upper right) After complete RNase A and T1 digest, the wild type FMRP RNase-resistant complex migrates at the size of the native I304N FMRP complex (fractions 13 and 14) as does FXR1P. The RNase-resistant FXR2P complex migrates in fractions 12 and 13. (Lower right) The I304N-FMRP complex does not shift in apparent size after RNase treatment. FXR1P and FXR2P shift in a similar way in the Fmr1I304N lysate as they do in the presence of wild-type FMRP. In all conditions, hsp90 migrates in fractions 11 and 12. An irrelevant RNA binding protein, Nova, runs as several isoforms, two of about 68 kDa and three of approx. 52 kDa. Their migration is identical in Fmr1I304N and wt lysates (fraction 12-14), and they are shifted to smaller size after RNase treatment in both lysates (fraction 13-15). (B) The RNase-resistant complex containing I304N-FMRP is larger than a monomer of I304N-FMRP alone. I304N fusion protein was denatured, added to a mouse brain lysate, and run on the same system to determine the migration of a monomer of I304N-FMRP. It was detected in fraction 15-16 using an anti-HisTag antibody.
###end p 43
###begin p 44
###xml 308 317 308 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g006">Figure 6A</xref>
###xml 422 431 422 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g006">Figure 6A</xref>
###xml 591 596 <span type="species:ncbi:10090">mouse</span>
To assess whether the loss of I304N-FMRP from larger complexes might result from a loss of protein-RNA interaction, we treated brain cytoplasmic extracts with excess RNase prior to Superose 6 gel filtration. Under these conditions, the WT FMRP complex size was reduced to the size of the I304N-FMRP complex (Figure 6A, upper panels, compare fractions 4-5 and 13-14), but the I304N complex did not change in apparent size (Figure 6A, lower panels); similar results were seen when EDTA was omitted from the lysis buffer (data not shown). This suggests that relative to FMRP, the I304N-FMRP in mouse brain has lost most or all of its ability to associate with RNA. We cannot rule out binding to small RNAs that would not affect migration on Superose 6 columns (those less than approximately200 nucleotides (66 kDa), which we estimate would shift Superose 6 migration). We note that a small amount of I304N-FMRP is present in the void volume in an RNase sensitive manner, which could be due to heterodimerization with other RNA binding proteins or residual RNA interactions from other FMRP RNA binding domains.
###end p 44
###begin title 45
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse brain I304N FMRP retains some functional domains
###end title 45
###begin p 46
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 617 626 617 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g006">Figure 6B</xref>
###xml 278 283 <span type="species:ncbi:10090">mouse</span>
###xml 339 344 <span type="species:ncbi:10090">mouse</span>
To assess whether the I304N protein retains reported biologic activities in vivo, we evaluated whether it was competent to interact with protein partners. We first compared the size of the RNase-treated I304N FMRP complex with that of denatured, recombinant I304N-FMRP added to mouse brain extract by Superose 6 gel filtration. Endogenous mouse brain I304N-FMRP was found in a complex significantly larger (fractions 13 and 14) than the I304N recombinant protein added to the same extract (fraction 15), suggesting that the native I304N protein in brain is capable of protein interactions independent of RNA binding (Figure 6B).
###end p 46
###begin p 47
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Zhang1">[46]</xref>
###xml 127 135 127 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Laggerbauer1">[63]</xref>
###xml 559 568 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g007">Figure 7A</xref>
###xml 750 758 750 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g004">Figure 4</xref>
###xml 760 769 760 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g007">Figure 7B</xref>
###xml 97 102 <span type="species:ncbi:4932">yeast</span>
###xml 305 310 <span type="species:ncbi:10090">mouse</span>
###xml 743 748 <span type="species:ncbi:10090">mouse</span>
FMRP was previously found to heterodimerize with its two autosomal homologs, FXR1P and FXR2P, by yeast two-hybrid assays [46]. In vitro studies indicated that I304N FMRP retains the ability to heterodimerize with FXR1P and FXR2P [63]. We analyzed the ability of endogenous I304N-FMRP to heterodimerize in mouse brain by immunoprecipitating I304N protein and assaying for co-precipitating FXR1P and FXR2P by Western blot. These experiments demonstrated that FXR1P and FXR2P co-precipitated with WT and I304N-FMRP, but not in control IPs from FMRP null brains (Figure 7A). Less FXR1P and FXR2P are co-precipitated by I304N-FMRP as compared with wild-type FMRP, but this is likely to be accounted for by the lower FMRP levels in the I304N mutant mouse (Figure 4, Figure 7B, third panel).
###end p 47
###begin title 48
I304N-FMRP retains the ability to heterodimerize and bind G-quartet RNA.
###end title 48
###begin p 49
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 52 57 52 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 320 324 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 324 329 324 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 481 489 481 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 523 525 523 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
(A) Brain lysates for IP were prepared from WT, Fmr1I304N (I304N) and Fmr1 null (KO) mice, and FMRP IPed with 7G1-1 antibody. Immunoprecipitates were probed by Western blot for co-IP of FXR1P (left panel) and FXR2P (right panel). Approximately 5% of the input lysate was run in lane 1. (B) Brain extracts from adult WT, Fmr1I304N (I304N), and Fmr1 null (KO) mice were incubated with radiolabeled RNA (G-quartet RNA (left panel) and kissing complex RNA (middle panel)) generated by in vitro transcription in the presence of 32P-UTP. Samples were UV crosslinked (XL), immunoprecipitated with FMRP specific 7G1-1 antibody, run on SDS-PAGE gels, transferred to nitrocellulose and exposed by phosphorimaging to detect radiolabeled RNA crosslinked to FMRP (open arrowhead). The same immunoprecipitates (IP) were probed for FMRP by Western blot using antibody 2F5 (right panel, filled arrowhead).
###end p 49
###begin p 50
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell1">[51]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell3">[64]</xref>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Schaeffer1">[65]</xref>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell1">[51]</xref>
###xml 525 533 525 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 921 930 921 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g007">Figure 7B</xref>
###xml 1133 1142 1133 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g007">Figure 7B</xref>
###xml 1257 1265 1257 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1265 1269 1265 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell1">[51]</xref>
###xml 1270 1274 1270 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell3">[64]</xref>
###xml 1766 1770 1766 1770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1770 1775 1770 1775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 2150 2154 2150 2154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 2154 2159 2154 2159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
###xml 561 566 <span type="species:ncbi:10090">mouse</span>
###xml 1055 1060 <span type="species:ncbi:10090">mouse</span>
###xml 1127 1131 <span type="species:ncbi:10090">mice</span>
###xml 1341 1346 <span type="species:ncbi:10090">mouse</span>
###xml 1426 1431 <span type="species:ncbi:10090">mouse</span>
###xml 1627 1632 <span type="species:ncbi:10090">mouse</span>
###xml 1776 1781 <span type="species:ncbi:10090">mouse</span>
###xml 2160 2165 <span type="species:ncbi:10090">mouse</span>
In vitro RNA selection studies identified a kissing complex RNA that is bound with high affinity by the FMRP KH2 domain [51] and a G-quartet RNA ligand for the C-terminal RGG-type RNA binding domain [64],[65]. Recombinant I304N-FMRP produced in insect cells has been shown to bind to G-quartet RNA, but not the kissing complex RNA [51]. We therefore examined endogenous I304N-FMRP in mouse brain to determine whether it recapitulated these RNA binding properties. Radiolabeled G-quartet or kissing complex RNA synthesized by in vitro transcription was added to mouse brain lysates, UV-crosslinked, immunoprecipitated with an antibody against FMRP and crosslinked RNA detected by autoradiography after SDS-PAGE. A radiolabeled FMRP:RNA complex was seen specifically in the immunoprecipitate of the I304N-FMRP extract crosslinked to the G-quartet RNA, but little or no I304N protein was crosslinked to kissing complex RNA (Figure 7B). When compared with the wild type FMRP, the reduced radioactive signal from G-quartet RNA crosslinked to the I304N-FMRP in mouse brain was consistent with lower I304N-FMRP levels in the knock-in mice (Figure 7B, third panel). Point mutants of G-quartet or mutant kissing complex RNAs, which are not bound by recombinant FMRP in vitro[51],[64] did not crosslink to either endogenous wild type or I304N-FMRP in mouse brain (data not shown). Taken together, these data indicate that I304N-FMRP in mouse brain retains some normal properties, as it is competent to bind both protein and, via its RGG-domain, to bind G-quartet RNA. RGG-domain RNA binding to RNA over 200nt is not evident in the I304N mouse, suggesting either that it plays a minor or dependent role to KH2 binding to large RNAs. Therefore a major biochemical defect in the Fmr1I304N mouse is the loss of KH2-dependent RNA binding. While other interpretations cannot be ruled out, including the loss of KH2-dependent interaction with a protein partner, taken together our data suggest that the resulting loss of polysome association and, presumably, proper regulation of translation of FMRP mRNA targets, is most likely to contribute to the phenotype of the Fmr1I304N mouse.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-DeBoulle1">[10]</xref>
###xml 476 484 476 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1054 1058 1054 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1171 1175 1171 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1292 1296 1292 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 224 231 <span type="species:ncbi:9606">patient</span>
###xml 531 538 <span type="species:ncbi:9606">patient</span>
###xml 781 788 <span type="species:ncbi:9606">patient</span>
###xml 995 1000 <span type="species:ncbi:10090">mouse</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
###xml 1181 1185 <span type="species:ncbi:10090">mice</span>
###xml 1383 1387 <span type="species:ncbi:10090">mice</span>
###xml 1516 1519 <span type="species:ncbi:10090">P14</span>
The Fragile X Syndrome is usually caused by a triplet repeat expansion in the 5'UTR of the FMR1 gene leading to transcriptional silencing of the FMR1 mRNA and failure to produce the FMRP protein product. A severely affected patient has offered possible insight into a key function of FMRP, as he harbors a missense (I304N) mutation in the KH2 RNA binding domain [10]. The I304N mutation has previously been shown to abrogate RNA binding of similar KH-type RNA binding domains in vitro, suggesting that the disease symptoms in this patient are caused by the loss of FMRP KH2 domain sequence-specific RNA binding. However, it has not been clear whether the I304N mutation abolishes RNA binding in neurons nor that this mutation alone causes the Fragile X symptoms in this individual patient, as his clinical picture is complicated by an unrelated familial liver disease, X-linked liver glycogenosis due to phosphorylase kinase deficiency. To address these issues, we have generated and analyzed a mouse model harboring the I304N mutation in the endogenous Fmr1 locus. These mice exhibit many of the phenotypic (macroorchidism), electrophysiologic and behavioral changes of Fmr1 null mice, and thereby indicate that the I304N mutation is sufficient to phenocopy transcriptional silencing of the Fmr1 gene. Surprisingly, we find both that FMRP RNA binding is lost in the brains of these mice, establishing a connection between KH2 RNA binding and the neurologic disorder, and that protein levels are markedly reduced at P14, a time of synaptogenesis in the neocortex and other brain areas.
###end p 52
###begin title 53
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
I304N mice have a Fmr1 null-like phenotype
###end title 53
###begin p 54
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 139 144 139 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fxr2</italic>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fxr2</italic>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Peier1">[53]</xref>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Spencer1">[66]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Bontekoe1">[69]</xref>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 496 501 496 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 564 568 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 822 826 822 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 864 868 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Spencer3">[68]</xref>
###xml 912 916 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Chen1">[70]</xref>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Frankland1">[71]</xref>
###xml 1041 1045 1041 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1045 1050 1045 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 1212 1219 1212 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000758-t001">Table 1</xref>
###xml 1320 1324 1320 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
###xml 292 297 <span type="species:ncbi:10090">mouse</span>
###xml 313 318 <span type="species:ncbi:10090">mouse</span>
###xml 365 370 <span type="species:ncbi:10090">mouse</span>
###xml 386 391 <span type="species:ncbi:9606">human</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 832 836 <span type="species:ncbi:10090">mice</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
Behavioral changes in the Fmr1 null mouse relative to either wild-type or mutant littermates have been well described. We compared the Fmr1I304N mouse to wild-type littermates on the same background and using many of the same assays employed for extensive behavioral testing of the Fmr1 null mouse, the Fxr2 null mouse, double knockout of both Fmr1 and Fxr2, and a mouse overexpressing human FMRP from a transgenic YAC construct [53], [66]-[69]. In most cases the phenotype of the KH2 mutant Fmr1I304N mice was similar to the previously published phenotype of the Fmr1 null mice, including increased audiogenic seizure rates, decreased acoustic startle responses, and assays indicating greater exploratory behavior, decreased anxiety responses and increased perseveration. Our results measuring PPI, while consistent with Fmr1 null mice assessed in our laboratory [68], differed from those of some investigators [70],[71]; it is possible that strain differences may account for some of this discrepancy. In summary, our behavioral assays of Fmr1I304N mice indicate that they show abnormalities in the same tests, in the same direction, and to similar levels in all assays previously performed in our laboratory (Table 1), strongly supporting the conclusion that the I304N mutation is sufficient to phenocopy loss of the Fmr1 gene.
###end p 54
###begin p 55
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Huber2">[72]</xref>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Huber1">[11]</xref>
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Koekkoek1">[13]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Volk1">[16]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Hou1">[60]</xref>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Nosyreva1">[61]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Ronesi1">[73]</xref>
###xml 601 605 601 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 605 610 605 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 657 665 657 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g003">Figure 3</xref>
###xml 952 956 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 956 961 956 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 995 999 995 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1044 1048 1044 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Koekkoek1">[13]</xref>
###xml 1049 1053 1049 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Volk1">[16]</xref>
###xml 1054 1058 1054 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Hou1">[60]</xref>
###xml 1059 1063 1059 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Nosyreva1">[61]</xref>
###xml 1135 1139 1135 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1379 1383 1379 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Chaouloff1">[74]</xref>
###xml 1520 1524 1520 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1524 1529 1524 1529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 1593 1597 1593 1597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1648 1652 1648 1652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Ronesi1">[73]</xref>
###xml 1653 1657 1653 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Park1">[75]</xref>
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
###xml 962 966 <span type="species:ncbi:10090">mice</span>
###xml 1218 1222 <span type="species:ncbi:10090">mice</span>
###xml 1530 1534 <span type="species:ncbi:10090">mice</span>
###xml 1603 1607 <span type="species:ncbi:10090">mice</span>
Metabotropic glutamate receptor-dependent LTD is a hippocampal synaptic plasticity paradigm that relies on rapid protein synthesis in dendrites [72]. Previous work in the Fmr1 null mouse demonstrated that LTD is enhanced and independent of new protein synthesis and translational regulators, such as ERK and Homer [11],[13],[16],[60],[61],[73]. From these studies, it was suggested that FMRP regulates the translation of the dendritic mRNAs required for mGluR-LTD expression. Here we demonstrate that LTD induced with either chemical or synaptic stimulation is independent of protein synthesis in the Fmr1I304N mice, recapitulating the Fmr1 null phenotype (Figure 3). This suggests that FMRP must interact with polyribosomes or kissing-complex RNAs for normal mGluR-LTD regulation. Alternatively, the effects on LTD could be due to a hypomorphic expression of I304N-FMRP. It is unclear why we did not detect alterations in the magnitude of LTD between Fmr1I304N mice and wildtype littermates or Fmr1 null littermates as demonstrated previously [13],[16],[60],[61]. We also found no significant enhancement of LTD between wild type and Fmr1 null littermates in the current study. This may be due to the fact that older mice were used in this study (40-90 day) than in previous work (21-35 day) or other factors such as stress levels, which are known to impact mGluR-LTD magnitude [74]. Subtle genetic background differences may also play a role. Notably, the independence of LTD on protein synthesis, as seen here in the Fmr1I304N mice appears to be a more robust and reproducible phenotype in Fmr1 null mice in comparison to enhanced LTD magnitude [73],[75].
###end p 55
###begin p 56
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Turner1">[55]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Peier1">[53]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-DutchBelgian1">[54]</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Dolen1">[76]</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Peier1">[53]</xref>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 300 305 300 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-DutchBelgian1">[54]</xref>
###xml 466 469 466 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-1">[6]</xref>
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 510 515 510 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
###xml 171 176 <span type="species:ncbi:10090">mouse</span>
###xml 265 270 <span type="species:ncbi:9606">human</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 451 456 <span type="species:ncbi:9606">human</span>
###xml 457 465 <span type="species:ncbi:9606">patients</span>
Macroorchidism is a profound clinical finding in postpubertal Fragile X patients, affecting more than 90% of adult male patients [55]. In mouse models, the Fragile X null mouse has a 20-25% increase in testicular size [53],[54],[76] which is rescued by a wild type human FMRP transgene [53]. The Fmr1I304N mice display the same degree of macroorchidism as their null counterparts, and this increases with age, as in the Fmr1 null mice [54] and in the human patients [6], supporting the conclusion that the Fmr1I304N mutation is sufficient to phenocopy the Fragile X Syndrome.
###end p 56
###begin title 57
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Biochemical analysis of I304N mice
###end title 57
###begin p 58
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 166 171 166 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dfmr1</italic>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Banerjee1">[77]</xref>
###xml 399 414 <span type="species:ncbi:10090">transgenic mice</span>
Steady-state levels of endogenous I304N-FMRP were found to be decreased relative to WT FMRP. While all of the characteristic isoforms of FMRP are observed in the Fmr1I304N tissues, they are expressed at lower levels than in wild type littermates. The post-transcriptional reduction in steady state levels of I304N-FMRP compared with mRNA levels has also been observed in two lines of I304N-FMRP BAC transgenic mice (data not shown), and in I307N-dfmr1 flies, which have the analogous mutation to I304N-FMRP in mammals [77]. Taken together, these data suggest that decreased protein levels are intrinsic to the mutation rather than a result of our genetic manipulation.
###end p 58
###begin p 59
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Feng2">[25]</xref>
###xml 731 735 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 816 825 816 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g004">Figure 4E</xref>
###xml 1052 1056 1052 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Schaeffer1">[65]</xref>
###xml 1203 1207 1203 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 210 217 <span type="species:ncbi:9606">patient</span>
###xml 1142 1147 <span type="species:ncbi:10090">mouse</span>
Lower steady state levels of I304N FMRP in brain and testes are surprising in light of previous data demonstrating that I304N FMRP is expressed at normal levels in EBV transformed lymphoblastoid cells from the patient with the I304N mutation [25] and may be due to the fact that a different cell type was studied or that EBV transformation altered normal FMRP expression. We find that steady state levels of I304N-FMRP are too low in cultured primary neurons to permit standard pulse-chase immunoprecipitation experiments to quantify I304N FMRP synthesis and turnover (data not shown). Another means of assessing FMRP synthesis is to analyze the distribution of its mRNA on polyribosome sucrose gradients. We have shown that I304N-Fmr1 mRNA has a normal profile on polyribosomes compared with wild-type littermates (Figure 4E), suggesting that decreased protein synthesis is not likely to account for decreased protein levels. It has been reported that FMRP can bind a G-quartet motif in the coding sequence of its own mRNA, inhibiting its translation [65]. However, we find no evidence to support the consequent prediction that in the I304N mouse there would be an increase in translation of the I304N-Fmr1 mRNA. Taken together, it seems most likely that the observed decrease in I304N protein levels is due to increased turnover of the mutant protein.
###end p 59
###begin p 60
###xml 113 129 113 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g004">Figure 4A and 4B</xref>
###xml 247 251 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Nimchinsky1">[19]</xref>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 84 87 <span type="species:ncbi:10090">P14</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
Interestingly, the decrease in I304N FMRP levels is much more pronounced in mice at P14, relative to older mice (Figure 4A and 4B). This correlates with the observation that there are transient alterations in the morphology of dendritic spines in Fmr1 null mice [19]. This suggests that the biochemical defect present in I304N FMRP may be compounded by a decrease in its levels during synaptogenesis, and that the phenotype may result from a combination of these effects.
###end p 60
###begin title 61
I304N FMRP is defective in polyribosome association and RNA binding
###end title 61
###begin p 62
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 216 224 216 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Siomi2">[40]</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell1">[51]</xref>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Musco1">[78]</xref>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Brown1">[79]</xref>
###xml 484 492 484 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell1">[51]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell3">[64]</xref>
###xml 727 735 727 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 937 941 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Feng2">[25]</xref>
###xml 1063 1071 1063 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g006">Figure 6</xref>
###xml 1127 1136 1127 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g007">Figure 7A</xref>
###xml 1138 1142 1138 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Laggerbauer1">[63]</xref>
###xml 1193 1202 1193 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g007">Figure 7B</xref>
###xml 794 802 <span type="species:ncbi:9606">patients</span>
Several attempts have been made to assess the effect of the I304N mutation on FMRP RNA binding and function. Recombinant or in vitro translated I304N FMRPs show significantly decreased binding to ribohomopolymers or in vitro-selected RNA ligands [40],[51],[78]. Other studies have found that recombinant I304N FMRP produced in insect cells retained some ribohomopolymer binding, but with decreased binding to poly-U [79]. The I304N mutation in FMRP abrogates binding to high affinity in vitro selected KH2 target RNA ligands (kcRNA) but not RGG target (G-quartet) RNAs, as assessed with both full-length FMRP and isolated RNA binding domains [51],[64], indicating that KH-specific RNA interactions are lost in the I304N mutant in vitro. However, in lymphoblastoid cell lines derived from I304N patients, some I304N-FMRP was able to be captured on oligo-dT columns, which was interpreted as showing that I304N mRNA association was intact [25]. We also find that some I304N FMRP is retained in the void volume of the Superose 6 column in an RNase-dependent manner (Figure 6), which may be due to heterodimerization with FXR1/2P (Figure 7A; [63]), or to residual RNA binding from the RGG domain (Figure 7B).
###end p 62
###begin p 63
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Pozdnyakova1">[80]</xref>
###xml 627 631 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Liu1">[81]</xref>
###xml 692 696 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Lewis1">[50]</xref>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Ramos2">[49]</xref>
###xml 1360 1368 1360 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000758-g007">Figure 7</xref>
###xml 1465 1473 1465 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1608 1615 1608 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1936 1943 1936 1943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 515 525 <span type="species:ncbi:7227">Drosophila</span>
###xml 1193 1198 <span type="species:ncbi:10090">mouse</span>
The conclusion that I304N FMRP KH2 domain fails to bind RNA in vivo is consistent with structural studies of several RNA-binding proteins suggesting that this mutation should affect RNA binding. Most studies of isolated protein domains (vigilin KH6, FMRP KH1, and Nova-2 KH3) have predicted that the I304N mutation results in an unfolded KH domain, which would be expected to lead to loss of specific RNA binding. However, other KH domains harboring mutations analogous to I304N are correctly folded, including the Drosophila homolog of FMRP (dfmr1p) tandem KH1-KH2 [80], and BBP/SF1, in which RNA binding is specifically lost [81]. The first co-crystal of a KH domain-RNA complex (Nova-RNA) [50], as well as a subsequent review of structures [49], suggest that mutation of the conserved hydrophobic amino acid analogous to Ile-304 must decrease RNA binding affinity. While a consensus from these KH domain:RNA structures is that the isoleucine mutation disrupts KH:RNA interactions, FMRP has multiple RNA binding domains, so that RNA binding by the full-length protein may not be abrogated despite loss of KH-dependent interactions. This is consistent with our observation that I304N-FMRP in mouse brain fails to crosslink to kcRNA, but retains other activities, including the ability to crosslink to G-quartet RNA and to heterodimerize with FXR1P and FXR2P (Figure 7). While we show that the RGG box in the I304N-FMRP is still competent to bind its high affinity in vitro-selected (G-quartet) RNA ligand, it appears from the Superose 6 analysis that I304N-FMRP has lost most of all of its RNA interactions in vivo. We propose that RNA binding by the other RNA-binding domains of FMRP may be hierarchical, such that the KH2 domain must make proper RNA interactions for subsequent G-quadruplex binding by the RGG box to occur. Taken together these observations suggest that the I304N-FMRP mutation leads to a global loss of RNA binding in vivo, and suggest that identification of FMRP KH2-RNA targets will be of great interest.
###end p 63
###begin title 64
I304N FMRP does not appear to have a dominant negative effect
###end title 64
###begin p 65
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 416 421 416 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 57 64 <span type="species:ncbi:9606">patient</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 633 636 <span type="species:ncbi:10090">P14</span>
###xml 699 704 <span type="species:ncbi:10090">mouse</span>
###xml 935 940 <span type="species:ncbi:10090">mouse</span>
###xml 962 967 <span type="species:ncbi:9606">human</span>
###xml 968 976 <span type="species:ncbi:9606">patients</span>
The severity of Fragile X symptoms reported in the I304N patient has led to the hypothesis that I304N-FMRP might have a dominant negative effect on its autosomal paralogs, FXR1P and FXR2P, decreasing any functional redundancy present in the absence of FMRP. We do not detect any evidence for this as the expression levels, polyribosomal association and mRNP complex sizes of FXR1P and FXR2P are unchanged in the Fmr1I304N mouse brain relative to wild type littermates. At the same time, we find that mutant protein levels vary with age, such that they are reduced (by two-thirds) in adult mice, but are even more markedly reduced at P14, a time when synaptogenesis is occurring in many areas of the mouse brain, including the forebrain and cerebellum. This finding suggests that loss of FMRP activity, including but not necessarily limited to KH2 RNA binding, may play a critical role in leading to the synaptic defects evident in the mouse, and, presumably, in human patients.
###end p 65
###begin p 66
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 48 53 48 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 190 195 190 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 424 429 424 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 574 579 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dfmr1</italic>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Banerjee1">[77]</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 369 374 <span type="species:ncbi:10090">mouse</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 563 573 <span type="species:ncbi:7227">Drosophila</span>
###xml 786 793 <span type="species:ncbi:9606">patient</span>
###xml 842 849 <span type="species:ncbi:9606">patient</span>
In addition, we find that macroorchidism in Fmr1I304N mice, while pronounced compared with wild type littermates, is no more severe than in Fmr1 null littermates. mGluR-dependent LTD in Fmr1I304N mice is equivalent to that in Fmr1 null littermates, but not enhanced. Behavioral assays give little or no indication of a more severe behavioral deficit than the Fmr1 null mouse. Taken together, these findings suggest that Fmr1I304N mice have an Fmr1 null-like phenotype, consistent with a loss of function mutation. Supporting this, the analogous I307N mutation in Drosophila dfmr1 results in a partial loss of function phenotype [77]. We propose that the severe Fragile X symptoms, including IQ below 20, lack of verbal communication, and impressive macroorchidism observed in the I304N patient may be a result of selection bias, in that this patient may have been selected for further gene sequencing precisely due to the severity of his Fragile X phenotype. Because screening for Fragile X Syndrome is currently performed by PCR for the CGG repeat expansion, negative results may be classified as nonsyndromic mental retardation or nonspecific developmental delay, in the absence of characteristic features of Fragile X Syndrome.
###end p 66
###begin p 67
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dfmr1</italic>
###xml 656 660 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Banerjee1">[77]</xref>
###xml 58 65 <span type="species:ncbi:9606">patient</span>
###xml 207 214 <span type="species:ncbi:9606">patient</span>
###xml 356 363 <span type="species:ncbi:9606">patient</span>
###xml 415 422 <span type="species:ncbi:9606">patient</span>
###xml 592 597 <span type="species:ncbi:10090">mouse</span>
###xml 709 716 <span type="species:ncbi:9606">patient</span>
Although we cannot exclude that the severity of the I304N patient's symptoms may have contributions from other genetic factors, including exacerbation by his familial liver disease, we note that none of the patient's other 29 relatives affected by liver glycogenosis have mental retardation, or the neurologic and phenotypic defects found in the Fragile X patient. We cannot rule out the possibility that the I304N patient might express elevated I304N FMRP levels such that a dominant negative action exacerbates his symptoms. Nonetheless, based on our finding of decreased I304N FMRP in the mouse model and similar results from the I307N mutation in dfmr1[77], we infer that it is most likely that the I304N patient has lower steady state levels of neuronal I304N-FMRP.
###end p 67
###begin title 68
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
A new mouse model for the Fragile X Syndrome
###end title 68
###begin p 69
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 8 13 8 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 142 148 142 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Cgr</sup>
###xml 138 148 138 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>tm1Cgr</sup></italic>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 288 294 288 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Cgr</sup>
###xml 284 294 284 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>tm1Cgr</sup></italic>
###xml 477 483 477 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Cgr</sup>
###xml 473 483 473 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>tm1Cgr</sup></italic>
###xml 674 677 674 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Khalil1">[8]</xref>
###xml 678 681 678 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Ladd1">[9]</xref>
###xml 705 711 705 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Cgr</sup>
###xml 701 711 701 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1<sup>tm1Cgr</sup></italic>
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
###xml 149 154 <span type="species:ncbi:10090">mouse</span>
###xml 330 335 <span type="species:ncbi:9606">human</span>
###xml 432 437 <span type="species:ncbi:9606">human</span>
###xml 438 446 <span type="species:ncbi:9606">patients</span>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
###xml 717 722 <span type="species:ncbi:10090">mouse</span>
###xml 917 922 <span type="species:ncbi:10090">mouse</span>
###xml 938 943 <span type="species:ncbi:9606">human</span>
###xml 950 957 <span type="species:ncbi:9606">patient</span>
###xml 979 984 <span type="species:ncbi:10090">mouse</span>
###xml 1050 1055 <span type="species:ncbi:9606">human</span>
###xml 1089 1096 <span type="species:ncbi:9606">patient</span>
The Fmr1I304N mouse provides an additional mouse model for the Fragile X Syndrome. The most widely used model for Fragile X Syndrome, the Fmr1tm1Cgr mouse, is a complete null due to the insertion of the neo cassette in exon 5 of the Fmr1 gene. By causing loss of FMRP expression, the Fmr1tm1Cgr mutation largely recapitulates the human Fragile X Syndrome at the protein level. Nonetheless, the CGG repeat expansion, present in most human patients, is not replicated in the Fmr1tm1Cgr null mouse, and the repeat may contribute in unknown ways to the disorder (soaking up CGG DNA binding proteins, or interfering with expression of transcripts present on the other DNA strand [8],[9]). In addition, the Fmr1tm1Cgr null mouse still contains a neo-expression cassette, which has been documented in some cases to affect expression of neighboring genes and lead to confounding phenotypes. Thus as a model system, the I304N mouse genocopies the human I304N patient better than the null mouse genocopies the CGG repeat expansion. However, we appreciate that human deletions and the point mutation patient, to the extent that they share all the symptoms of Fragile X Syndrome, argue against the CGG repeat expansion itself playing a significant role in the disease, and that the I304N mutation is limited in clinical significance relative to the CGG expansion.
###end p 69
###begin p 70
###xml 616 623 616 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 669 674 669 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 712 716 712 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-DutchBelgian1">[54]</xref>
###xml 728 732 728 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Mientjes1">[82]</xref>
###xml 764 768 764 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 789 793 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Peier1">[53]</xref>
###xml 903 907 903 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 907 912 907 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 503 508 <span type="species:ncbi:10090">mouse</span>
###xml 675 680 <span type="species:ncbi:10090">mouse</span>
###xml 773 788 <span type="species:ncbi:10090">transgenic mice</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
The I304N mutation causes defective KH2-mediated RNA binding in neurons, and decreased FMRP levels, particularly in younger animals. The loss of KH2 function accounts for the dissociation of the protein from brain polyribosomes. We propose that this leads to a loss of proper translational control of FMRP mRNA targets, which in turn leads to the cognitive and behavioral deficits observed in the Fragile X Syndrome. Our observations underscore the importance of identifying FMRP KH2 RNA ligands in the mouse brain to understand the pathogenesis of the disease. Identification of a reliable and comprehensive set of in vivo RNA targets will benefit from use of the Fmr1I304N mouse model, in conjunction with the Fmr1 null [54], Fmr1 conditional knockout [82], and FMR1 YAC transgenic mice [53] for validation and functional studies. Finally, trials of potential clinical treatments can be tested on the Fmr1I304N mice, since they provide an additional animal model in which rescue of phenotype can be measured.
###end p 70
###begin title 71
Materials and Methods
###end title 71
###begin title 72
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
Generation of targeted Fmr1 I304N knock-in mutation
###end title 72
###begin p 73
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 916 920 916 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FMR1</italic>
###xml 949 950 949 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</sup>
###xml 1488 1492 1488 1492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fxr1</italic>
###xml 1496 1500 1496 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fxr2</italic>
###xml 1506 1510 1506 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Kirkpatrick1">[83]</xref>
###xml 29 35 <span type="species:ncbi:10090">murine</span>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
###xml 900 905 <span type="species:ncbi:10090">mouse</span>
###xml 910 915 <span type="species:ncbi:9606">human</span>
###xml 1482 1487 <span type="species:ncbi:10090">mouse</span>
A genomic clone encoding the murine Fmr1 gene was isolated from a BAC library derived from a 129 mouse (ES-129/SvJ BAC library, clone address 217I21, Incyte Genomics). To generate an Fmr1 KH2 I304N targeting vector, a 7.2 kb BamHI-XhoI 5' homology arm spanning intron 5 to intron 9 and a 1.9kb XhoI-KpnI fragment spanning intron 9 to intron 11 (including exon 10 where the I304N mutation occurs, and a 3' homology arm (1.3kb)) were cloned into pBluescriptIISK(+) (Stratagene). PCR mutagenesis of the XhoI-KpnI fragment introduced the I304N mutation in exon 10 to change the sequence CTG(Leu) ATT(Ile) CAA(Gln) to CTT(Leu) AAC(Asn) CAG(Gln)). The two wobble mutations were introduced to create a new HindIII site for genotyping and to facilitate PCR genotyping with a mutant-specific primer. A new XbaI site was also generated in the middle of intron 10 in a region that was not conserved between the mouse and human FMR1 genes. The loxP-Auto-Cre-NeoR-loxP (ACNF) cassette (from Dr. Peter Mombaerts) was inserted in the new XbaI site. Finally, the 5' homology arm and the XhoI-(I304N)-(ACNF)-KpnI fragment were ligated together into the pBluescript plasmid. The plasmid was linearized with NotI and used to electroporate ES cells at the Transgenic Services Laboratory at The Rockefeller University. Genomic DNA from individual colonies was digested with BamHI and screened by Southern blot analysis. The Southern probe overlapping exon 12, which has no corresponding sequence in the mouse Fxr1 or Fxr2 gene [83], distinguished the targeted allele, 2.7 kb, from wild type locus, 9.6 kb. Correctly targeted clones were selected for blastocyst injection and transferred to pseudopregnant females, from which germline chimeras were obtained.
###end p 73
###begin p 74
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 4 17 4 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm(I304N)Drnl</sup>
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 23 28 23 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 148 153 148 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 165 170 165 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 207 212 207 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 258 265 258 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N/+</sup>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 414 419 414 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 424 428 424 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 446 450 446 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 450 460 450 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N/null</sup>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
Fmr1tm(I304N)Drnl (Fmr1I304N) mice were bred greater than 10 generations into FVB and C57BL/6J backgrounds to generate the congenic strains FVB.Fmr1I304N and B6.Fmr1I304N. To generate wild-type (wt) and Fmr1I304N mutant littermates on either background, Fmr1I304N/+ heterozygous (het) females were bred with wild-type (wt) males of the same background and male offspring were used for experiments. To generate Fmr1I304N and Fmr1 null littermates Fmr1I304N/null het females were bred with wt male mice and male offspring used.
###end p 74
###begin title 75
RNA preparation
###end title 75
###begin p 76
###xml 175 183 175 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
RNA from mouse tissues or polyribosome fractions was extracted using Trizol or Trizol LS Reagent, respectively, according to manufacturer's instructions (Invitrogen). 10ng of in vitro translated luciferase RNA was spiked into each polyribosome fraction as a control for RNA recovery. Chloroform:isoamyl alcohol (49:1) was added, samples spun at 15min at 12,000xg, the aqueous phase collected and precipitated with ethanol at -20degreesC overnight. RNA was pelleted at 20,000xg for 20min at 4degreesC, washed with 75% ethanol, and dissolved in water. RNA was then RQ1 DNase (Promega) treated at 37degreesC for 1hr and underwent a second round of phenol-chloroform extraction and ethanol precipitation.
###end p 76
###begin title 77
Northern blots
###end title 77
###begin p 78
###xml 371 373 365 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 383 387 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
Northern blots were performed following the NorthernMax-Gly protocol (Ambion). Briefly, 30ug of brain RNA and 10ug of testes RNA were denatured with Glyoxal load dye at 50degreesC for 30min and then were separated on a 0.8% agarose gel in 1x Gel Prep/Gel Running buffer. RNA was transferred to a GeneScreen Plus hybridization transfer membrane (Perkin Elmer) in 10x SSC. 32P-labeled Fmr1 probe (see below) was hybridized to the membrane at 68degreesC for 2 hrs in QuikHyb hybridization solution (Stratagene). beta-actin probe was hybridized at 42degreesC for 1hr in ULTRAhyb-Oligo solution (Ambion). Membranes were then washed with 2x SSC, 0.1% SDS and 0.1x SSC, 0.1% SDS at room temperature. Radiolabel was detected and quantified by PhosphorImager (Bio-Rad).
###end p 78
###begin p 79
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 59 67 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 88 90 88 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Fmr1 probe, complementary to the 3'UTR, was synthesized by in vitro transcription with P32-alpha-UTP using the MAXIscript kit (Ambion) according to the manufacturer's protocol. Template DNA for transcription was generated using a reverse primer that included the T7 promoter sequence (underlined).
###end p 79
###begin p 80
###xml 2 32 2 32 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TCAGCAGTATGTTTCAGTCTTTCGG 3&#8242;</named-content>
F:5'TCAGCAGTATGTTTCAGTCTTTCGG 3'
###end p 80
###begin p 81
###xml 4 22 4 22 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAATACGACTCACTATAG</underline>
###xml 2 59 2 59 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;<underline>TAATACGACTCACTATAG</underline>GGGAGAGTTTTCAAAGTTGAAATTCGTCATCAGG 3&#8242;</named-content>
R:5'TAATACGACTCACTATAGGGGAGAGTTTTCAAAGTTGAAATTCGTCATCAGG 3'
###end p 81
###begin p 82
###xml 83 85 80 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
A 20nt long DNA anti-sense probe against beta-actin exon 4 was 5' end labeled with 32P-ATP with T4 polynucleotide kinase (NEB) and used for Northern blots.
###end p 82
###begin title 83
Histopathology and testicular measurement
###end title 83
###begin p 84
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 142 147 142 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 168 172 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 700 704 700 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 704 709 704 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 748 752 748 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1049 1053 1049 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 91 96 <span type="species:ncbi:10090">Mouse</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 979 983 <span type="species:ncbi:10090">mice</span>
Histopathology analysis was performed by the Rockefeller University Genetically Engineered Mouse Phenotyping core facility. Four male FVB.Fmr1I304N mice, five male FVB.Fmr1 null littermates and four FVB wild-type mice were sacrificed at 10 weeks of age and tissues fixed in 10% formalin overnight and embedded in paraffin blocks. Tissue sections were deparaffinized, rehydrated, stained with hematoxylin & eosin, and visualized with a Zeiss Axioplan microscope. For testicular analysis, seminiferous tubule diameters were measured and interstitial cell numbers were counted under randomly selected 20x power fields, blind to genotype. Macroorchidism was assessed by combined weight of both testes of Fmr1I304N mice compared to that of either wt or Fmr1 null littermates at indicated ages. Measurements from multiple litters of similar ages were pooled and subjected to statistical analysis (student's t-test). Both histology and testicular size measurements were performed using mice bred greater than 10 generations into the C57BL/6 background (B6.Fmr1 null breeding pairs were generously provided by Dr. W. Greenough, U. Illinois)).
###end p 84
###begin title 85
Behavioral analysis
###end title 85
###begin p 86
###xml 3 7 3 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 7 14 7 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N/+</sup>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 315 322 315 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N/+</sup>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Peier1">[53]</xref>
###xml 556 560 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Spencer3">[68]</xref>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">Mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
B6.Fmr1I304N/+ heterozygous female mice were shipped to Baylor College of Medicine where they were embryo rederived by mating with male C57BL/6J mice. Female offspring were backcrossed an additional generation to C57BL/6J male mice. Mice used for behavioral analysis were generated by mating these mice with B6.Fmr1I304N/+ heterozygous females and were maintained at the same B6 backcross generation. All mice started testing between 2-3 months of age by experimenters blind to the genotype of the mice using behavioral protocols previously described [53],[68]. Twenty-three mutant and 18 wild-type littermates were evaluated for this study.
###end p 86
###begin p 87
Behavioral results were analyzed using SPSS. Data were analyzed using one- and two-way ANOVA with repeated measures as appropriate. Significant interactions were analyzed using simple-effects follow-up comparisons. Levels of significance were set at p</=0.05.
###end p 87
###begin title 88
Electrophysiology
###end title 88
###begin p 89
###xml 67 71 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 71 76 67 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 101 105 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 136 140 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Huber1">[11]</xref>
###xml 141 145 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Nosyreva1">[61]</xref>
###xml 439 440 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 442 443 434 435 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 456 457 448 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 467 468 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 477 478 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Hippocampal slices (400microm) were prepared from 30-90 day old B6.Fmr1I304N mice and their wt or B6.Fmr1 null littermates as described [11],[61]. All experiments were performed blind to genotype and in the presence of the NMDA receptor antagonist D,L-AP5 (50 microM; Tocris) to isolate mGluR-dependent LTD. D,L-AP5 and anisomycin were prepared fresh daily in artificial cerebrospinal fluid which consists of (in mM) NaCl, 124; KCl, 5; NaH2PO4, 1.25; NaHCO3, 26; MgCl2, 1; CaCl2, 2; dextrose, 10. Extracellular field potentials (FPs) were measured in the stratum radiatum of hippocampal CA1 elicited by Schaffer collateral stimulation. mGluR-LTD was induced by application of 100microM DHPG for 5min or by pairs of stimuli (50 msec interstimulus interval) delivered at 1 Hz for 20 min (2400 pulses; PP-LFS). Synaptic strength was measured as the initial slope (10-40% of the rising phase) of the FP. LTD magnitude was compared at 60-70min after the onset of DHPG or PP-LFS. Slices were preincubated in antagonists or inhibitors for 20-30 min before DHPG or PP-LFS. The effects of all pharmacological treatments on LTD were evaluated by comparing interleaved control and treated slices. Independent t-tests were used to determine statistical significance.
###end p 89
###begin title 90
Total protein extract for western blot
###end title 90
###begin p 91
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 4 9 4 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
Fmr1I304N mice and their wild type littermates on the FVB background were used for determining FMRP levels by western blot. Tissues were Dounce homogenized in lysis buffer (0.5% NP-40, 0.5% deoxycholic acid, 0.1% SDS in PBS, 50% glycerol, and 1x Complete protease inhibitor cocktail (Roche)) sonicated to fully disrupt nuclei, shear nucleic acids and disrupt macromolecular complexes, and spun at 20,000xg at 4degreesC for 15min. Protein concentration was determined by Bradford assay compared with BSA standards. 50ug of protein from each sample was boiled in SDS-sample buffer and used for western analysis.
###end p 91
###begin title 92
Antibodies
###end title 92
###begin p 93
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Gabel1">[84]</xref>
###xml 341 345 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Brown2">[85]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Ceman1">[86]</xref>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Buckanovich1">[87]</xref>
###xml 670 675 <span type="species:ncbi:9606">human</span>
###xml 676 683 <span type="species:ncbi:9606">patient</span>
###xml 802 807 <span type="species:ncbi:10090">mouse</span>
###xml 814 820 <span type="species:ncbi:9986">rabbit</span>
###xml 830 835 <span type="species:ncbi:9606">human</span>
The following antibodies were used throughout the work: anti-FMRP mab2160 at 1:1000 for immunoblot (IB) (Chemicon), anti-FMRP 2F5 at 1:100 for IB [84], anti-FMRP ab17722 at 1:1000 for immunoblot (Abcam), anti-FMRP 7G1-1 ascites (Developmental Studies Hybridoma Bank (DSHB), University of Iowa) at 1:100 for IB, also used for IP as described [85],[86], anti-FXR1P ML13 at 1:10,000 for IB (gift from Dr. E. Khandjian (Universite Laval, Quebec)), anti-FXR2P 1G2 concentrated supernatant at 1:100 for IB (DSHB), anti-hsp90 at 1:5000 for IB (BD Biosciences), anti-gamma tubulin (GTU-88, Sigma) at 1:10,000 for IB, anti-ribosomal S6 protein at 1:1000 for IB (Cell Signaling), human patient serum against Nova at 1:1000 for IB [87], HRP-conjugated anti-His-tag at 1:5000 for IB (Novagen). HRP-conjugated anti-mouse, anti-rabbit, or anti-human IgG at 1:10,000 for IB (Jackson Immunoresearch).
###end p 93
###begin title 94
Western blot
###end title 94
###begin p 95
Samples were run on 8% or 4-12% gradient SDS-polyacrylamide gels and transferred to Immobilon-P membranes (Millipore) by standard methods. Membranes were blocked for 1hr at room temperature in 10% non-fat dry milk in western blot wash buffer (WBWB) (23mM Tris, pH 8.0, 190mM NaCl, 0.1% w/v BSA, 1mM EDTA, 0.5% Triton X-100, 0.02% SDS). Primary antibodies in 10% milk in WBWB were used during incubation for 1 hr at room temperature or overnight at 4degreesC. Blots were washed with WBWB 5 times for 5 min after each antibody incubation. Signals were detected by enhanced chemiluminescence (Western Lightning detection kit, Perkin Elmer) and quantified with a Versadoc Imaging System (Bio-Rad).
###end p 95
###begin title 96
Quantitative RT-PCR
###end title 96
###begin p 97
Purified RNA was reverse transcribed using random hexamers (Roche) and Superscript III reverse transcriptase (Invitrogen) according to manufacturer's protocols. cDNA products were amplified using SYBR green PCR master mix (Applied Biosystems) with 200nM of the following primers.
###end p 97
###begin p 98
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 31 61 31 61 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGAAAACAACTGGCAACCAGAGAG-3&#8242;</named-content>
Fmr1 1F (spanning exon 2 to 3) 5'-TGAAAACAACTGGCAACCAGAGAG-3'
###end p 98
###begin p 99
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 31 59 31 59 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGGTGGTGGGAATCTCACATC-3&#8242;</named-content>
Fmr1 1R (spanning exon 2 to 3) 5'-CAGGTGGTGGGAATCTCACATC-3'
###end p 99
###begin p 100
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 33 61 33 61 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTCAGGAGTTGTGAGGGTGAGG-3&#8242;</named-content>
Fmr1 2F (spanning exon 10 to 11) 5'-GTCAGGAGTTGTGAGGGTGAGG-3'
###end p 100
###begin p 101
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 33 61 33 61 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAAGGTAGGGAACTTGGTGGC-3&#8242;</named-content>
Fmr1 2R (spanning exon 10 to 11) 5'-GGAAGGTAGGGAACTTGGTGGC-3'
###end p 101
###begin p 102
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 8 34 8 34 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATGGCCTTCCGTGTTCCTA-3&#8242;</named-content>
Gapdh F 5'-CATGGCCTTCCGTGTTCCTA-3'
###end p 102
###begin p 103
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 8 31 8 31 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGGCACGTCAGATCCA-3&#8242;</named-content>
Gapdh R 5'-GCGGCACGTCAGATCCA-3'
###end p 103
###begin p 104
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Luc</italic>
###xml 6 33 6 33 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCTTGATTGACAAGGATGGA-3&#8242;</named-content>
Luc F 5'-GCCTTGATTGACAAGGATGGA-3'
###end p 104
###begin p 105
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Luc</italic>
###xml 6 33 6 33 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGAGACTTCAGGCGGTCAAC-3&#8242;</named-content>
Luc R 5'-CAGAGACTTCAGGCGGTCAAC-3'
###end p 105
###begin p 106
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 641 645 641 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 764 768 764 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 769 770 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 786 791 786 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 792 793 792 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 794 797 794 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0.5</sup>
###xml 838 842 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 846 851 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 977 981 969 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1046 1050 1038 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1403 1407 1395 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 1408 1409 1400 1401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1429 1430 1421 1422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1431 1434 1423 1426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0.5</sup>
Quantitative PCR amplification was performed using a 7900HT sequence detection system (Applied Biosystems) at the Genomic Resource Center at The Rockefeller University. Fluorimetric intensity of SYBR green was monitored during each cycle of amplification to quantify mRNA levels. Regression curves were drawn for each sample and relative amount of mRNA was calculated from the threshold cycles using the instrument's software, SDS 2.0. For expression levels in total brain, relative levels of Fmr1 mRNA were measured using the standard curve method and normalized to the internal control GAPDH mRNA. Three pairs of littermates were used for Fmr1 mRNA determination by Q-PCR. Error was calculated using the formula suggested by the ABI user bulletin, [(std dev for Fmr1)2 + (std dev for Gapdh)2]0.5 For polyribosome distribution, relative Fmr1 or Gapdh mRNA level in each fraction was normalized to spiked-in luciferase RNA analyzed using the DeltaDeltaCt method. The amount of Fmr1 mRNA in each fraction was then plotted as a percentage of total Fmr1 mRNA summed over the entire polyribosome gradient. Q-PCR experiments were each repeated 2 times with two pairs of biologic replicates. Error bars reflect the technical replicates from triplicate wells in a single representative experiment from polysome gradients. Error is calculated using the formula suggested by the ABI user bulletin, [(std dev for Fmr1)2 + (std dev for luc)2]0.5. Because of gradient variability from day to day they cannot be plotted together so a representative experiment is shown.
###end p 106
###begin title 107
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse brain polyribosome analysis
###end title 107
###begin p 108
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Stefani1">[27]</xref>
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell1">[51]</xref>
###xml 290 291 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 464 465 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1043 1044 1031 1032 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
Mouse brain polyribosomes were prepared essentially according to established protocols [27],[51]. Briefly, 2 week-old mice were sacrificed by isoflurane anaesthesia and decapitation. The brain was removed and placed in ice-cold dissection buffer (10mM HEPES-KOH, pH 7.4, 150mM KCl, 5mM MgCl2, 100ug/ml cycloheximide). Cortex and cerebellum were dissected free of underlying white matter, homogenized in 1ml lysis buffer (10mM HEPES-KOH, pH 7.4, 150mM KCl, 5mM MgCl2, 0.5mM dithiothreitol, 100ug/ml cycloheximide, 1x Complete EDTA-free protease inhibitor cocktail (Roche), 40U/ml rRNAsin (Promega)) per brain with 12 strokes at 900rpm in a motor-driven Teflon-glass homogenizer. The homogenate was spun at 2000xg for 10min at 4degreesC. The supernatant (S1) from the homogenized material was collected and adjusted to 1% NP-40, incubated for 5min on ice, and spun at 20,000xg for 10min at 4degreesC. The resulting supernatant (S2) was loaded onto a 20-50% w/w linear density gradient of sucrose in 10mM HEPES-KOH pH 7.4, 150mM KCl, and 5mM MgCl2. Gradients were centrifuged at 40,000 rpm for 2 hrs at 4degreesC in a Beckman SW41 rotor. Fractions of 0.75ml volume were collected with continuous monitoring at 260nm using an ISCO UA-6 UV detector. 400 ul of each fraction was TCA precipitated and analyzed by Western blot.
###end p 108
###begin title 109
Superose 6 gel filtration
###end title 109
###begin p 110
###xml 275 280 <span type="species:ncbi:10090">Mouse</span>
###xml 1294 1299 <span type="species:ncbi:10090">mouse</span>
A pre-packed Superose 6 Precision column PC 3.2/30 in a SMART system (GE Healthcare) was used to determine the molecular masses of protein complexes. The optimal separation range of globular proteins in this column is 5 kDa to 5000 kDa with an exclusion limit of 40,000 kDa. Mouse brain cytoplasmic lysates (0.3% NP-40, 10mM HEPES, pH 7.4, 150mM KCl, either with or without 30mM EDTA) were spun over a 0.22um Spin-X column (Corning) before loading onto a Superose 6 column with a flow rate of 30ul/min. Protein profile was monitored at A280nm and fractions of 75ul were collected. Fractions were TCA precipitated for Western analysis. To calibrate the column, protein markers (GE Healthcare) were run and gave the following results: blue dextran (void >/=40,000 kDa) in fraction 4, 669 kDa at the fraction 10/11 boundary, 440 kDa in fraction 13, 67 kDa in fraction 15/16 and 13.7 kDa in fraction 18. Molecular mass was extrapolated by linear regression analysis for each fraction according to the migration of these protein markers and used for identification of protein complex sizes we studied. The average MW in each fraction was: fraction 12 (463 kDa), 13 (261 kDa), 14 (148 kDa), 15 (83 kDa) and 16 (47 kDa). For complete RNase digestion, recombinant RNase A and T1 (Ambion) were added to mouse brain lysates to a final concentration of 20 ug/ml and 10,000 U/ml respectively. Lysates were incubated at room temperature for 30 min before gel filtration.
###end p 110
###begin title 111
Co-immunoprecipitation of FMRP and FXR1/2P
###end title 111
###begin p 112
###xml 79 85 <span type="species:ncbi:9986">rabbit</span>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
A 1:1 slurry of protein A Sepharose beads (Sigma) was first bound to 120 ug of rabbit anti-mouse Fcgamma bridging antibody (Jackson ImmunoResearch) for 20 minutes at room temperature, washed 3 times in 0.1 M phosphate buffer pH 8.1, and bound to 10 ul of anti-FMRP monoclonal 7G1-1 ascites (5mg/ml, DSHB, U. Iowa). Brain cytoplasmic lysates were prepared in lysis buffer (0.5% Triton X-100, 30mM HEPES, pH 7.4, 200mM NaCl, 30mM EDTA, and Complete protease inhibitor cocktail (Roche)), by Dounce homogenization of one adult brain in 2 ml lysis buffer and centrifugation at 20,000xg for 10 minutes at 4 degrees, and were incubated with beads and antibodies at 4degreesC for 2 hrs. Immunoprecipitates were washed four times with the same lysis buffer. Sepharose beads were heated to 95degrees in SDS sample loading buffer and supernatants analyzed by Western analysis.
###end p 112
###begin title 113
T7 transcription and directed UV crosslinking IP
###end title 113
###begin p 114
###xml 55 59 55 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell1">[51]</xref>
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Darnell3">[64]</xref>
###xml 70 78 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 97 99 97 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 115 117 111 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 407 411 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000758-Ule1">[88]</xref>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
96nt long G-quartet (GQ) and kissing complex (kc) RNAs [51],[64] were in vitro transcribed with P32-alpha-UTP and P32-alpha-GTP. RNAs were gel purified on denaturing gels and spiked into 100ul S2 brain lysate prepared as for polyribosome analysis from 2 month old mice of the indicated genotype. RNAs were incubated with the brain lysates for 15 min at room temperature and then UV crosslinked as described [88]. Lysates were then diluted with 500 ul stringent IP buffer (0.5% NP-40, 0.5% deoxycholic acid, 0.1% SDS in PBS) and the IP was performed as for the co-immunoprecipitation, with the exception that stringent IP buffer was both the IP and wash buffer. Immunoprecipitates were run on 4-12% SDS-PAGE, transferred to nitrocellulose membranes, and exposed by autoradiography.
###end p 114
###begin title 115
Supporting Information
###end title 115
###begin p 116
###xml 46 51 46 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 487 492 487 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
Light micrographs of sagittal sections of Fmr1I304N knock-in mouse brains and testes reveal no microscopic abnormality. Post mortem mouse organs were fixed in 10% formalin, paraffin embedded, sectioned, and stained with hematoxylin & eosin. (A,B) Wild-type cerebellum, (C,D) I304N cerebellum, (E,F) wild-type cortex, (G,H) I304N cortex, (I,J) wild-type hippocampus, (K,L) I304N hippocampus, (M,N) wild-type testes, and (O,P) I304N testes and photographed at two magnifications. FVB. Fmr1I304N mice have normal seminiferous tubular diameter (wild type tubular diameter = 177.5+/-21.4 microm, n = 30 and I304N tubular diameter = 176.0+/-17.3 microm, n = 30, p>0.05), normal interstitial mass without edema (wild-type interstitial cell number = 33+/-8, n = 10, I304N interstitial cell number = 32+/-5, n = 10, under 20x field, p>0.05), and normal spermatogenesis.
###end p 116
###begin p 117
(0.85 MB PDF)
###end p 117
###begin p 118
Click here for additional data file.
###end p 118
###begin p 119
###xml 25 30 25 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I304N</sup>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
Behavorial assays in Fmr1I304N mice and their wild type littermates. The findings for both day 1 and day 2 were similar; day 1 data are presented, and details for each assay are given below. Assays performed were as follows. Activity in open field test: (A) total distance traveled, (B) vertical distance (rearing). Anxiety related responses: (C) center:total distance ratio in an open field, (D) light to dark transition, (E) time spent in the dark chamber. Startle habituation: (F) acoustic startle response in PPI test, (G) %PPI with increasing prepulse level. Conditioned fear: (H) number of freezing bouts in the context test, (I) number of freezing bouts in the acoustic conditioned stimulus test. (J) Hotplate test for sensitivity to pain as measured by latency of response. (K) Number of marbles buried as a measure of obsessive-compulsive behavior. (L) % of mice displaying audiogenic seizure in response to a stimulus.
###end p 119
###begin p 120
(0.07 MB PDF)
###end p 120
###begin p 121
Click here for additional data file.
###end p 121
###begin p 122
Locomotor activity in an open field, anxiety related responses, acoustic startle and prepulse inhibition of the startle, conditioned fear, hotplate, marble bury, audiogenic seizure.
###end p 122
###begin p 123
(0.04 MB DOC)
###end p 123
###begin p 124
Click here for additional data file.
###end p 124
###begin p 125
###xml 386 390 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fmr1</italic>
###xml 390 396 390 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Cgr</sup>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
We thank Dr. Guang-Lin Yin, Nishath Rehman, and Katie Staudt for excellent technical assistance and Dr. Gulayse Ince Dunn for her generous assistance with primary neuronal cultures. We thank members of our laboratories for helpful discussions and critical review of the work. We also thank Dr. Peter Mombaerts for the ACNF cassette, Dr. Bill Greenough for breeding pairs of the C57Bl/6 Fmr1tm1Cgr null mice, and Dr. Eduoard Khandjian for the anti-FXR1P antibody. The 7G1-1 antibody, developed by Dr. Stephanie Ceman and Dr. Steve Warren, and the 1G2 antibody, developed by Dr. Alan Tartakoff, were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.
###end p 125
###begin title 126
References
###end title 126
###begin article-title 127
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.
###end article-title 127
###begin article-title 128
###xml 91 95 <span type="species:ncbi:10090">mice</span>
A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice.
###end article-title 128
###begin article-title 129
###xml 71 79 <span type="species:ncbi:9606">patients</span>
High frequency of neurexin 1beta signal peptide structural variants in patients with autism.
###end article-title 129
###begin article-title 130
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.
###end article-title 130
###begin article-title 131
Genetic basis of Rett syndrome.
###end article-title 131
###begin article-title 132
A decade of molecular studies of fragile X syndrome.
###end article-title 132
###begin article-title 133
A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome.
###end article-title 133
###begin article-title 134
An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals.
###end article-title 134
###begin article-title 135
A point mutation in the FMR-1 gene associated with fragile X mental retardation.
###end article-title 135
###begin article-title 136
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
Altered synaptic plasticity in a mouse model of fragile X mental retardation.
###end article-title 136
###begin article-title 137
Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency.
###end article-title 137
###begin article-title 138
Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome.
###end article-title 138
###begin article-title 139
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Age-dependent and selective impairment of long-term potentiation in the anterior piriform cortex of mice lacking the fragile X mental retardation protein.
###end article-title 139
###begin article-title 140
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene FMR1.
###end article-title 140
###begin article-title 141
Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in fragile X syndrome mental retardation.
###end article-title 141
###begin article-title 142
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome.
###end article-title 142
###begin article-title 143
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome.
###end article-title 143
###begin article-title 144
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Abnormal development of dendritic spines in FMR1 knock-out mice.
###end article-title 144
###begin article-title 145
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.
###end article-title 145
###begin article-title 146
Adult fragile X syndrome. Clinico-neuropathologic findings.
###end article-title 146
###begin article-title 147
Analysis of neocortex in three males with the fragile X syndrome.
###end article-title 147
###begin article-title 148
The fragile X mental retardation protein is associated with ribosomes.
###end article-title 148
###begin article-title 149
The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes.
###end article-title 149
###begin article-title 150
FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association.
###end article-title 150
###begin article-title 151
Fragile X mental retardation protein-nucleocytoplasmic shuttling and association with somatodendritic ribosomes.
###end article-title 151
###begin article-title 152
Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells.
###end article-title 152
###begin article-title 153
Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.
###end article-title 153
###begin article-title 154
Fragile X-related protein and VIG associate with the RNA interference machinery.
###end article-title 154
###begin article-title 155
###xml 2 12 <span type="species:ncbi:7227">Drosophila</span>
A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins.
###end article-title 155
###begin article-title 156
A micrococcal nuclease homologue in RNAi effector complexes.
###end article-title 156
###begin article-title 157
Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway.
###end article-title 157
###begin article-title 158
Switching from repression to activation: microRNAs can up-regulate translation.
###end article-title 158
###begin article-title 159
AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2.
###end article-title 159
###begin article-title 160
Transport of fragile X mental retardation protein via granules in neurites of PC12 cells.
###end article-title 160
###begin article-title 161
Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons.
###end article-title 161
###begin article-title 162
The fragile X mental retardation protein-RNP granules show an mGluR-dependent localization in the post-synaptic spines.
###end article-title 162
###begin article-title 163
A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability.
###end article-title 163
###begin article-title 164
The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.
###end article-title 164
###begin article-title 165
Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome.
###end article-title 165
###begin article-title 166
Fragile X Mental Retardation protein determinants required for its association with polyribosomal mRNPs.
###end article-title 166
###begin article-title 167
The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding.
###end article-title 167
###begin article-title 168
The structure of the N-terminal domain of the fragile X mental retardation protein: a platform for protein-protein interaction.
###end article-title 168
###begin article-title 169
Mutational analysis establishes a critical role for the N terminus of fragile X mental retardation protein FMRP.
###end article-title 169
###begin article-title 170
The fragile X syndrome: exploring its molecular basis and seeking a treatment.
###end article-title 170
###begin article-title 171
The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2.
###end article-title 171
###begin article-title 172
The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals.
###end article-title 172
###begin article-title 173
A nuclear role for the Fragile X mental retardation protein.
###end article-title 173
###begin article-title 174
The role of a clinically important mutation in the fold and RNA-binding properties of KH motifs.
###end article-title 174
###begin article-title 175
Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome.
###end article-title 175
###begin article-title 176
Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes.
###end article-title 176
###begin article-title 177
Targeting genes for self-excision in the germ line.
###end article-title 177
###begin article-title 178
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features.
###end article-title 178
###begin article-title 179
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Fmr1 knockout mice: a model to study fragile X mental retardation.
###end article-title 179
###begin article-title 180
X-linked mental retardation, macro-orchidism, and the Xq27 fragile site.
###end article-title 180
###begin article-title 181
###xml 8 12 <span type="species:ncbi:10090">mice</span>
Fmr1 KO mice as a possible model of autistic features.
###end article-title 181
###begin article-title 182
###xml 3 7 <span type="species:ncbi:10090">mice</span>
Of mice and the fragile X syndrome.
###end article-title 182
###begin article-title 183
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
###end article-title 183
###begin article-title 184
The use of behavioral test batteries: effects of training history.
###end article-title 184
###begin article-title 185
Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression.
###end article-title 185
###begin article-title 186
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
###end article-title 186
###begin article-title 187
FMRP RNA targets: identification and validation.
###end article-title 187
###begin article-title 188
Evidence that fragile X mental retardation protein is a negative regulator of translation.
###end article-title 188
###begin article-title 189
Fragile X mental retardation protein targets G Quartet mRNAs important for neuronal function.
###end article-title 189
###begin article-title 190
The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif.
###end article-title 190
###begin article-title 191
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
###end article-title 191
###begin article-title 192
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 49 54 <span type="species:ncbi:9606">human</span>
Social behavior in Fmr1 knockout mice carrying a human FMR1 transgene.
###end article-title 192
###begin article-title 193
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
###end article-title 193
###begin article-title 194
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
Knockout mouse model for Fxr2: a model for mental retardation.
###end article-title 194
###begin article-title 195
###xml 10 14 <span type="species:ncbi:10090">mice</span>
Fragile X mice develop sensory hyperreactivity to auditory stimuli.
###end article-title 195
###begin article-title 196
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
###end article-title 196
###begin article-title 197
Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression.
###end article-title 197
###begin article-title 198
Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation.
###end article-title 198
###begin article-title 199
Acute stress facilitates hippocampal CA1 metabotropic glutamate receptor-dependent long-term depression.
###end article-title 199
###begin article-title 200
Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD.
###end article-title 200
###begin article-title 201
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Correction of fragile X syndrome in mice.
###end article-title 201
###begin article-title 202
###xml 58 68 <span type="species:ncbi:7227">Drosophila</span>
Substitution of critical isoleucines in the KH domains of Drosophila fragile X protein results in partial loss-of-function phenotypes.
###end article-title 202
###begin article-title 203
Three-dimensional structure and stability of the KH domain: molecular insights into the Fragile X syndrome.
###end article-title 203
###begin article-title 204
Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein.
###end article-title 204
###begin article-title 205
New insights into Fragile X syndrome. Relating genotype to phenotype at the molecular level.
###end article-title 205
###begin article-title 206
Structural basis for recognition of the intron branch site RNA by splicing factor 1.
###end article-title 206
###begin article-title 207
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo.
###end article-title 207
###begin article-title 208
Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2.
###end article-title 208
###begin article-title 209
Visual experience regulates transient expression and dendritic localization of fragile X mental retardation protein.
###end article-title 209
###begin article-title 210
Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in Fragile X Syndrome.
###end article-title 210
###begin article-title 211
Phosphorylation influences the translation state of FMRP-associated polyribosomes.
###end article-title 211
###begin article-title 212
Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system.
###end article-title 212
###begin article-title 213
CLIP identifies Nova-regulated RNA networks in the brain.
###end article-title 213
###begin article-title 214
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.
###end article-title 214
###begin p 215
The authors have declared that no competing interests exist.
###end p 215
###begin p 216
This work was supported by National Institutes of Health (R01 NS34389 (RBD), R01 NS40955 (RBD), R01 HD040647 (JCD), R01 NS045711 (KMH), R01 HD052731 (KMH)), Autism Speaks (KMH), the NICHD/NIH Fragile X Center at Baylor College of Medicine (RP), and NIH MSTP-GM07739 to JBZ. RBD is a Howard Hughes Medical Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 216

